BRAZE, INC., 10-K filed on 3/31/2023
Annual Report
v3.23.1
Cover - USD ($)
$ in Millions
12 Months Ended
Jan. 31, 2023
Mar. 24, 2023
Jul. 31, 2022
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 31, 2023    
Current Fiscal Year End Date --01-31    
Document Transition Report false    
Entity File Number 001-41065    
Entity Registrant Name Braze, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 45-2505271    
Entity Address, Address Line One 330 West 34th Street    
Entity Address, Address Line Two Floor 18    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10001    
City Area Code (609)    
Local Phone Number 964-0585    
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share    
Trading Symbol BRZE    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 2,400
Documents Incorporated by Reference Portions of the registrant’s Proxy Statement for its 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended January 31, 2023.    
Entity Central Index Key 0001676238    
Amendment Flag false    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Class A common stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   61,842,578  
Class B common stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   34,389,453  
v3.23.1
Audit Information
12 Months Ended
Jan. 31, 2023
Audit Information [Abstract]  
Auditor Firm ID 42
Auditor Name Ernst & Young LLP
Auditor Location New York, NY
v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
CURRENT ASSETS:    
Cash and cash equivalents $ 68,587 $ 478,937
Accounts receivable, net of allowance of $1,613 and $743 at January 31, 2023 and January 31, 2022, respectively 78,338 64,504
Marketable securities 410,083 35,156
Prepaid expenses and other current assets 26,163 29,588
Total current assets 583,171 608,185
Restricted cash, noncurrent 4,036 4,036
Property and equipment, net 20,339 7,393
Operating lease right-of-use assets 46,261 0
Deferred contract costs 48,451 41,689
Other assets 3,148 4,959
TOTAL ASSETS 705,406 666,262
CURRENT LIABILITIES:    
Accounts payable 3,101 2,083
Accrued expenses and other current liabilities 37,415 31,623
Deferred revenue 166,092 126,260
Operating lease liabilities, current 10,695 0
Total current liabilities 217,303 159,966
Operating lease liabilities, noncurrent 40,590 0
Other long-term liabilities 755 1,478
TOTAL LIABILITIES 258,648 161,444
COMMITMENTS AND CONTINGENCIES (Note 13)
Temporary Equity, Carrying Amount, Attributable to Parent   0
Redeemable non-controlling interest (Note 4) 1,455 3,235
STOCKHOLDERS’ EQUITY    
Additional paid-in capital 806,044 717,175
Accumulated other comprehensive loss (6,824) (640)
Accumulated deficit (353,927) (214,961)
TOTAL STOCKHOLDERS’ EQUITY 445,303 501,583
TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY 705,406 666,262
Class A common stock    
STOCKHOLDERS’ EQUITY    
Common stock 6 1
Class B common stock    
STOCKHOLDERS’ EQUITY    
Common stock $ 4 $ 8
v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Allowance for doubtful accounts $ 1,613 $ 743
Class A common stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, issued (in shares) 61,585,973 18,549,183
Common stock, outstanding (in shares) 61,585,973 18,549,183
Class B common stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized (in shares) 110,000,000 110,000,000
Common stock, issued (in shares) 34,389,453 74,418,847
Common stock, outstanding (in shares) 34,389,453 74,418,847
v3.23.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Income Statement [Abstract]      
Revenue $ 355,426 $ 238,035 $ 150,191
Cost of revenue 115,818 78,511 54,511
Gross Profit 239,608 159,524 95,680
Operating expenses:      
Sales and marketing 201,684 127,137 70,661
Research and development 97,293 59,034 29,212
General and administrative 88,771 51,564 27,959
Total operating expenses 387,748 237,735 127,832
Loss from operations (148,140) (78,211) (32,152)
Other income (expense), net 7,977 (121) 720
Loss before provision for income taxes (140,163) (78,332) (31,432)
Provision for (benefit from) income taxes 583 (165) 537
Net loss (140,746) (78,167) (31,969)
Net loss attributable to redeemable non-controlling interest (1,780) (1,448) (217)
Net loss attributable to Braze, Inc. $ (138,966) $ (76,719) $ (31,752)
Earnings Per Share      
Net loss per share attributable to Braze, Inc. common stockholders, basic (in dollars per share) $ (1.47) $ (2.20) $ (1.77)
Net loss per share attributable to Braze, Inc. common stockholders, diluted (in dollars per share) $ (1.47) $ (2.20) $ (1.77)
Weighted-Average Shares Outstanding      
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, basic (in shares) 94,569 34,897 17,972
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, diluted (in shares) 94,569 34,897 17,972
v3.23.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Statement of Comprehensive Income [Abstract]      
Net loss $ (140,746) $ (78,167) $ (31,969)
Other comprehensive loss:      
Change in foreign currency translation adjustments (633) (534) (26)
Unrealized losses on marketable securities (5,551) (64) (50)
Other comprehensive loss, net (6,184) (598) (76)
Comprehensive loss, net (146,930) (78,765) (32,045)
Less: comprehensive loss, net, attributable to redeemable non-controlling interest (1,780) (1,448) (217)
Comprehensive loss attributable to Braze, Inc. $ (145,150) $ (77,317) $ (31,828)
v3.23.1
Consolidated Statements of Convertible Preferred Stock, Redeemable Noncontrolling Interest and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Class A and B
Common Stock
Common Class A and B
Common Stock
Original common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated other Comprehensive Income (Loss)
Beginning balance at Jan. 31, 2020 $ 174,229            
Beginning balance, convertible preferred stock (in shares) at Jan. 31, 2020 62,831,000            
Ending balance, convertible preferred stock (in shares) at Jan. 31, 2021 62,831,000            
Ending balance at Jan. 31, 2021 $ 174,229            
Beginning balance at Jan. 31, 2020 0            
Noncontrolling Interest [Roll Forward]              
Investment in redeemable non-controlling interests 2,450            
Net loss attributable to redeemable non-controlling interest (217)            
Ending balance at Jan. 31, 2021 2,233            
Beginning balance (in shares) at Jan. 31, 2020     0 17,180,000      
Beginning balance at Jan. 31, 2020 (86,876)   $ 0 $ 0 $ 19,580 $ (106,490) $ 34
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for options exercised (in shares)       2,334,000      
Issuance of common stock for options exercised 2,482       2,482    
Vesting of early exercised options 263       263    
Repurchase of shares related to early exercised options (in shares)       (5,000)      
Repurchase of shares related to early exercised options 10       10    
Repurchase of common shares (in shares)       11,000      
Repurchase of common shares 204       204    
Stock-based compensation 7,666       7,666    
Other comprehensive loss (76)           (76)
Net loss attributable to Braze, Inc. (31,752)         (31,752)  
Ending balance at Jan. 31, 2021 $ (108,507)   $ 0 $ 0 29,777 (138,242) (42)
Ending balance (in shares) at Jan. 31, 2021     0 19,498,000      
Increase (Decrease) in Temporary Equity [Roll Forward]              
Conversion of convertible preferred stock to common stock (in shares) (62,831,000)            
Temporary Equity, Value, Conversion Of Convertible Securities $ (174,229)            
Ending balance, convertible preferred stock (in shares) at Jan. 31, 2022 0            
Ending balance at Jan. 31, 2022 $ 0            
Noncontrolling Interest [Roll Forward]              
Investment in redeemable non-controlling interests 2,450            
Net loss attributable to redeemable non-controlling interest (1,448)            
Ending balance at Jan. 31, 2022 $ 3,235            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for options exercised (in shares) 2,855,522   2,856,000        
Issuance of common stock for options exercised $ 8,166   $ 2   8,164    
Issuance of common stock for warrants exercised (in shares)   216,000          
Vesting of early exercised options (524)       (524)    
Vesting of restricted stock units (in shares)     70,000        
Repurchase of shares related to early exercised options (in shares)     (3,000)        
Stock-based compensation 47,567       47,567    
Other comprehensive loss (598)           (598)
Initial public offering, net of issuance costs (in shares)     7,500,000        
Initial public offering, net of issuance costs 456,921   $ 1   456,920    
Reclassification of common stock to class A and class B common stock (in shares)     19,498,000 (19,498,000)      
Conversion of convertible preferred stock into common stock (in shares)     62,831,000        
Conversion of convertible preferred stock to common stock 174,229   $ 6   174,223    
Net loss attributable to Braze, Inc. (76,719)         (76,719)  
Ending balance at Jan. 31, 2022 501,583   $ 9 $ 0 717,175 (214,961) (640)
Ending balance (in shares) at Jan. 31, 2022     92,968,000 0      
Noncontrolling Interest [Roll Forward]              
Net loss attributable to redeemable non-controlling interest (1,780)            
Ending balance at Jan. 31, 2023 $ 1,455            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for options exercised (in shares) 2,155,929   2,156,000        
Issuance of common stock for options exercised $ 8,456   $ 1   8,455    
Issuance of common stock under employee stock purchase plan (in shares)     125,000        
Issuance of common stock under employee stock purchase plan 2,876       2,876    
Vesting of early exercised options 145       145    
Vesting of restricted stock units (in shares)     631,000        
Repurchase of shares related to early exercised options (in shares)     (1,000)        
Stock-based compensation 73,133       73,133    
Other comprehensive loss (6,184)           (6,184)
Charitable donation of stock (in shares)     96,000        
Charitable donation of stock 4,260       4,260    
Net loss attributable to Braze, Inc. (138,966)         (138,966)  
Ending balance at Jan. 31, 2023 $ 445,303   $ 10   $ 806,044 $ (353,927) $ (6,824)
Ending balance (in shares) at Jan. 31, 2023     95,975,000        
v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss (including amounts attributable to redeemable non-controlling interests) $ (140,746) $ (78,167) $ (31,969)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation 72,243 47,180 7,540
Amortization of deferred contract costs 23,639 17,710 10,617
Depreciation and amortization 4,618 2,773 1,589
Provision for credit losses 807 88 853
Value of common stock donated to charity 4,260 0 0
Amortization of discount/premium on marketable securities 1,336 369 345
Non-cash foreign exchange loss (gain) 1,612 387 222
Other 495 (80) 60
Changes in operating assets and liabilities:      
Accounts receivable (14,650) (29,821) (12,354)
Prepaid expenses and other current assets 3,596 (17,537) (833)
Deferred contract costs (30,469) (31,967) (19,969)
ROU assets and liabilities 3,355 0 0
Other assets 1,711 (4,723) 643
Accounts payable 906 1,649 (776)
Accrued expenses and other current liabilities 5,075 6,026 13,797
Deferred revenue 39,894 51,471 23,378
Other long-term liabilities 10 (756) 777
Net cash used in operating activities (22,308) (35,398) (6,080)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of property and equipment (15,447) (2,310) (2,466)
Capitalized internal-use software costs (1,258) (2,065) (1,886)
Purchases of marketable securities (638,221) (36,894) (59,418)
Maturities of marketable securities 256,407 59,309 86,242
Net cash (used in)/provided by investing activities (398,519) 18,040 22,472
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from issuance of common stock upon initial public offering, net of offering costs 0 462,260 0
Investment from redeemable non-controlling interest 0 2,450 2,450
Proceeds from exercise of common stock options 11,332 8,362 2,813
Payment of deferred offering costs 0 (5,157) (183)
Repurchase of common shares 0 0 (204)
Repurchase of shares related to early exercised options 0 (5) (10)
Net cash provided by financing activities 11,332 467,910 4,866
Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash (855) (597) 158
Net change in cash, cash equivalents, and restricted cash (410,350) 449,955 21,416
Cash, cash equivalents, and restricted cash, beginning of period 482,973 33,018 11,602
Cash, cash equivalents, and restricted cash, end of period 72,623 482,973 33,018
SUPPLEMENTAL CASH FLOW DISCLOSURE:      
Cash paid for income taxes, net of refunds 365 299 472
NON-CASH INVESTING AND FINANCING ACTIVITIES:      
Stock-based compensation capitalized to internal-use software 1,121 387 126
Net change in capitalized internal-use software development costs in accrued expenses 21 (58) 62
Unrealized net loss on marketable investment securities (5,551) (64) (50)
Net change to property and equipment (included in accounts payable / accrued liabilities) 75 (23) (15)
Vesting of early exercised options 145 524 263
Common stock option receivables 0 22 0
Conversion of convertible preferred stock to common stock 0 174,229 0
Deferred offering costs reclassed to Stockholders’ Equity (Deficit) 0 183 0
Asset retirement obligation $ 374 $ 0 $ 0
v3.23.1
Company Overview
12 Months Ended
Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Company Overview Company Overview
Description of Business

Braze, Inc., together with its subsidiaries (collectively, the “Company”, “we”, “us”, “our” or “Braze”), is a cloud-based customer engagement platform that delivers customer-centric experiences across push notifications, email, in-product messaging, SMS and MMS messages, and more. Customers use the Braze platform to facilitate real-time experiences between brands and customers in a more authentic and human way.

We began operations in 2011 and are incorporated in the state of Delaware. Our headquarters are located in New York, New York. We also lease additional office space in Austin, Berlin, Chicago, Jakarta, London, Paris, San Francisco, Singapore, and Tokyo.

Emerging Growth Company Status

Based on the market value of the Company’s common equity held by non-affiliates as of July 29, 2022 (the last business day of the Company’s most recently completed second fiscal quarter), the Company ceased to qualify as an emerging growth company (as described in Section 107(b) of the Jumpstart Our Business Startups Act of 2012) as of the end of the fiscal year ended January 31, 2023. As a result, the Company will no longer be able to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. In addition, the Company will no longer be able to use the extended transition period for complying with new or revised accounting standards available to emerging growth companies and will be required to adopt new or revised accounting standards as of the effective dates for public companies.
v3.23.1
Summary of Significant Accounting Policies
12 Months Ended
Jan. 31, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, and variable interest entities (“VIE”) for which we are the primary beneficiary. Intercompany balances and transactions have been eliminated in consolidation.

Reclassifications

Certain reclassifications and immaterial changes have been made to prior-period financial statements to conform to the current-period presentation.
Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reported period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Significant items subject to such estimates and assumptions include, but are not limited to, the standalone selling price for separate performance obligations in our revenue arrangements, expected period of benefit for deferred contract costs, the valuation of common stock and stock-based compensation, the allocation of overhead costs between cost of revenue and operating expenses, the estimated useful lives of intangible and depreciable assets, the incremental borrowing rate, the valuation of deferred tax assets and liabilities and other tax estimates including our ability to utilize net operating losses.

Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments as facts and circumstances dictate. As future events and their effects, including the uncertainty surrounding rapidly changing market and economic conditions from the outbreak of COVID-19 or other significant macroeconomic events, cannot be determined with precision, actual results could differ from those estimates and many of our estimates and assumptions have required increased judgement and carry a higher degree of variability and volatility.
Basic and Diluted Net Loss attributable to Braze, Inc. Common Stockholders per Share

Basic and diluted net loss attributable to Braze, Inc. common stockholders per share is presented in conformity with the two-class method required for participating securities. Under the two-class method, net loss is attributed to common stockholders and participating securities based on their participation rights. Prior to our IPO, we considered all series of our convertible preferred stock to be participating securities. Under the two-class method, the net loss attributable to Braze, Inc. common stockholders is not allocated to the convertible preferred stock as the holders of our convertible preferred stock do not have a contractual obligation to share in our losses.

Basic loss attributable to Braze, Inc. per common stockholder’s share is computed by dividing the net loss by the weighted-average number of shares of Braze, Inc. common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss attributable to Braze, Inc. by the weighted-average number of shares of Braze, Inc. common stock together with the number of additional shares of Braze Inc. common stock that would have been outstanding if all potentially dilutive shares of Braze Inc. common stock had been issued. Since we were in a loss position for the periods presented, basic net loss per share attributable to Braze, Inc. common stockholders is the same as diluted net loss per share attributable to Braze, Inc. common stockholders since the effects of potentially dilutive securities are antidilutive.

Segment Reporting

Operating segments are defined as components of an entity for which discrete financial information is available that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. Our Chief Executive Officer (“CEO”) is the CODM. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. As such, we have one operating segment, which is the business of cloud-based customer engagement platform subscriptions.

Fair Value of Financial Instruments

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The guidance describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value.

Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date

Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities

Level 3 – Unobservable inputs that are supported by little or no market data for the related assets or liabilities

The categorization of a financial instrument within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Our financial instruments include cash equivalents, marketable securities, accounts receivable, accounts payable, and other current assets and liabilities. At January 31, 2023 and 2022, the carrying amounts of accounts receivable, accounts payable, and other current assets and liabilities approximated fair values because of their short-term nature.

Foreign Currency

The functional currency of our foreign subsidiaries is the local currency. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the exchange rate on the transaction date. Monetary assets and liabilities denominated in currencies other than the functional currency are remeasured at period-end using the period-end exchange rate. Gains and losses resulting from remeasurement are recorded in other income (expense), net, on the consolidated statements of operations. All assets and liabilities of foreign subsidiaries are translated at the current exchange rate as of the end of the period, retained earnings and other equity items are translated at historical rates, and revenue and expenses are translated at average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into U.S. dollars is reflected as foreign currency cumulative translation adjustments reported on the consolidated statements of comprehensive loss.
Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income (expense), net in the accompanying consolidated statements of operations when realized.

Cash and cash equivalents represent cash and highly liquid investments with original contractual maturities of three months or less at the date of purchase. Cash and cash equivalents consist of deposit accounts, interest-bearing money market accounts, and overnight short-term repurchase agreements that are stated at fair value.

As of January 31, 2023 and 2022, approximately $4.0 million and $4.0 million, respectively, of deposits were restricted due to multiple letters of credit related to our leased and subleased properties. These deposits were classified as current and noncurrent based on the related underlying lease term.

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash as of January 31, 2023 and 2022 (in thousands):
January 31,
20232022
Cash and cash equivalents$68,587 $478,937 
Restricted cash, noncurrent4,036 4,036 
Total cash, cash equivalents, and restricted cash$72,623 $482,973 

Accounts Receivable, Net and Credit Losses

Accounts receivable consists of customer obligations due under normal trade terms and are recorded at amounts billed and unbilled to customers, net of allowance for any potential uncollectible accounts. Unbilled amounts are included in trade accounts receivable, net, which generally arise from our contractual right to bill our customers in advance of services on the contract effective date. Trade accounts receivable are recorded at invoiced amounts and do not bear interest.

We maintain an allowance for credit losses for accounts receivable, net which is recorded as an offset to accounts receivable, net and changes in this allowance are recorded as general and administrative expenses in the consolidated statements of operations. We assess collectability by reviewing accounts receivable on a collective basis when similar characteristics exist and on an individual basis when we identify specific customers with known disputes or collectability issues. In determining the amount of the allowance for credit losses, we consider historical collectability based on past due status and make judgements about the creditworthiness of customers based on ongoing credit evaluations. A receivable is considered past due if we have not received payment based on agreed-upon terms. We also consider customer-specific information, current market conditions, and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss data. No material write-offs of accounts receivable have been recognized in any of the periods presented.

Concentration of Credit Risk

Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, marketable securities, and accounts receivable. Restricted cash consists of letters of credit related to our leased properties. For cash, cash equivalents, restricted cash, and marketable securities, we are exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the consolidated balance sheets in excess of the Federal Deposit Insurance Corporation (“FDIC”) limits. Cash, cash equivalents, restricted cash, and marketable securities balances are maintained at financial institutions that management believes are of high-credit, quality financial institutions, where deposits, at times, exceed the FDIC limits.

Significant customers are those which represent 10% or more of our total revenue for the period, or accounts receivable at the balance sheets dates. For fiscal years ended January 31, 2023 or 2022, no customer accounted for 10% or more of total revenue.

For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheets. As of January 31, 2023 or 2022, no customer accounted for 10% or more of our total accounts receivable balance.

Marketable Securities

We classify our investments in marketable securities within current assets on the consolidated balance sheets as the investments are available for use, if needed, in current operations as we may sell our marketable securities at any time, without
significant penalty, even if they have not yet reached maturity. These investments are carried at fair value, based on quoted market rates when observable or utilizing data points that are observable, such as quoted prices, interest rates and yield curves. Gains and losses are determined based on the specific identification method and are recognized when realized as a component of Other income, net in our consolidated statements of operations.

We review our securities on a regular basis to evaluate if any security has experienced an other-than temporary decline in fair value. We consider an available-for-sale security to be impaired if the fair value of the investment is less than its amortized cost basis, our intent to sell, or whether it is more likely than not that we are required to sell the security before recovery of its amortized cost basis. If we believe that an other-than-temporary decline exists in one of the securities, we will write down these investments to fair value. To the extent that the decline in fair value is related to credit losses, such as changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors, the write-down related to credit loss would be recorded in Other income, net in our consolidated statements of operations. Impairments related to factors other than credit losses are recognized in accumulated other comprehensive income (loss), net of tax. As of January 31, 2023, the Company had not recorded any credit impairments.

Property and Equipment, Net

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful life of the related asset. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred. Upon asset retirement or sale, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets, and the resulting gain or loss is reflected in general and administrative expenses in the consolidated statements of operations. The estimated useful lives for significant property and equipment categories are as follows:

Computer equipment, office equipment, and software
3 years
Furniture and fixtures
7 years
Leasehold improvementsShorter of lease term or estimated useful life of assets

Impairment of Long-Lived Assets

Long-lived assets, subject to depreciation and amortization, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of these assets or asset groups may not be recoverable or that the useful life is shorter than originally estimated. Recoverability of these assets or asset groups is measured by comparison of the carrying amount of each asset or asset group to the future undiscounted cash flows the asset or asset group is expected to generate over their remaining lives. If the asset or asset group is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset or asset group. If the useful life is shorter than originally estimated, we amortize the remaining carrying value over the new shorter useful life. There were no material impairment losses of long-lived assets recognized for the fiscal years ended January 31, 2023, 2022 and 2021.

Capitalized Internal-use Software Costs

We capitalize certain costs incurred to develop new or additional customer-facing software functionality, on the consolidated balance sheets as a component of property and equipment, net. We capitalize qualifying personnel costs, including stock-based compensation, and consulting costs incurred during the application development stage so long as the project is authorized, it is probable the project will be completed, and the software will be used to perform the function intended. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred and included in research and development expenses on the consolidated statements of operations. These capitalized costs are amortized over the software’s expected useful life, which is generally three years, within cost of revenue on the consolidated statements of operations.

Comprehensive Loss

Our comprehensive loss is currently comprised of unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.

Variable Interest Entity

A VIE is an entity that either has insufficient equity to permit the entity to finance its activities without additional subordinated financial support or has equity investors who lack the characteristics of a controlling financial interest. The primary beneficiary of a VIE is the party with both the power to direct the activities of the VIE that most significantly impact
the VIE’s economic performance and the obligation to absorb the losses or the right to receive benefits that could potentially be significant to the VIE.

To assess whether we have the power to direct the activities of a VIE that most significantly impact its economic performance, we consider all the facts and circumstances including our role in establishing the VIE and our ongoing rights and responsibilities. This assessment includes identifying the activities that most significantly impact the VIE’s economic performance and identifying which party, if any, has power over those activities. In general, the party that makes the most significant decisions affecting the VIE is determined to have the power to direct the activities of the VIE. To assess whether we have the obligation to absorb the losses or the right to receive benefits that could potentially be significant to the VIE, we consider all of our economic interests, including debt and equity interests, servicing rights and fee arrangements, and any other variable interests in the VIE. If we determine that we are the party with the power to make the most significant decisions affecting the VIE, and we have an obligation to absorb the losses or the right to receive benefits that could potentially be significant to the VIE, then we consolidate the VIE.

We perform ongoing reassessments of whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired or divested the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on new events, and therefore could be subject to the VIE consolidation framework.

Redeemable Non-controlling Interest

Redeemable non-controlling interests represent the portion of net income (loss), net, and comprehensive income (loss), net, that is not allocable to us, in situations where we consolidate an equity interest or as the primary beneficiary of a VIE for which there are other owners. The amount of non-controlling interest is comprised of the greater of the amount of such interests at the date of the original acquisition of an equity interest in an investment, plus the other shareholders’ share of changes in equity since the date of the investment or estimated redemption value. The resulting changes in the estimated redemption amount (increases or decreases) are recorded with corresponding adjustments against retained earnings or, in the absence of retained earnings, additional paid-in-capital. The redeemable non-controlling interest is classified outside of permanent equity as mezzanine equity on the consolidated balance sheets as the redemption option is outside of our control.

Revenue Recognition

We derive our revenue primarily from subscriptions to our platform, including associated support, and professional services. Our subscriptions do not provide customers with the right to take possession of the software supporting the applications and, as a result, are accounted for as service contracts. Professional services primarily consist of fees for distinct services rendered in training and assisting customers to configure and optimize the use of the platform. Revenue is recognized when control of the promised goods or services is transferred to clients in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We apply the following five-step model to recognize revenue from contracts with clients:

Identification of the contract or contracts with a customer;
Identification of the performance obligation(s) in the contract;
Determination of the transaction price;
Allocation of the transaction price to the performance obligation(s) in the contract; and
Recognition of revenue when, or as, a performance obligation is satisfied.

We identify the performance obligations in a contract or multiple contracts with a customer and determine whether they are distinct or distinct within the context of the contract. When there is more than one distinct performance obligation in a contract, we allocate the transaction price to the performance obligations on a relative standalone selling price basis based on standalone selling prices (“SSP”). We have identified two performance obligations within our contracts with our customers: (i) subscription and (ii) professional services and other.

All contracts generally contain fixed consideration payable upfront by the customer. Some of our multi-year arrangements may contain fixed fees with escalating pricing structures each year. The nature of our subscription performance obligation remains unchanged each period of the arrangement and therefore may create a contract asset reflecting the difference between the amount of revenue recognized compared to the amount billed.

Some of our contracts with customers contain terms, such as service level guarantees, product usage and overage fees, that, along with various potential claims, including breach of warranty, may result in variable consideration. Variable consideration exists when the amount which we expect to receive in a contract is affected by the occurrence or non-occurrence of future events. We develop estimates of variable consideration on the basis of historical information, current trends, and any other specific knowledge about future periods.
Variable consideration is included in the transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Typically, our contracts do not provide customers with any right of return or refund; however, we may make exceptions on a case-by-case basis when it makes commercial sense. Variable consideration, including as a result of service level guarantees, product usage and overage fees or other potential claims such as breach of warranty, was not material during the fiscal years ended January 31, 2023 and 2022. We allocate the variable consideration related to the product usages and overages to the distinct month during which the related services were performed as those fees relate specifically to providing usage of the platform in the period and represents the consideration we are entitled to for the access to the platform. As a result, the usage and overage fees are included in the transaction price and recognized as revenue in the period in which the fee was generated.

To the extent that we grant customers an option to acquire additional products or services, we account for the option as a distinct performance obligation in the contract only if the option provides a material right to the customer that the customer would not receive without entering into the contract. If a material right exists in a contract, revenue allocated to the option is deferred and recognized as revenue only when those future products or services are transferred or when the option expires. Contracts do not typically contain material rights and when they do, the material right has not been significant to our consolidated financial statements.

Once the transaction price is determined, the total transaction price is allocated to each performance obligation in a manner depicting the amount of consideration to which we expect to be entitled in exchange for transferring the products or services to the customer. This allocation is based on the SSP of the products or services included in the arrangement.

Judgment is required to determine the SSP for each performance obligation. We determine SSP based on observable prices for those related goods or services when sold separately, if available. When such observable prices are not available, we determine SSP based on overarching pricing objectives and strategies, taking into consideration market conditions and other factors, including transaction size, product-specific factors, historical sales of the deliverables and costs to deliver the services and applicable margins.

Subscription Services

Subscription revenue is recognized ratably over the contract term beginning on the commencement date of each contract, which is the date the platform is made available to customers. We have determined that subscriptions to our platform represent a stand-ready obligation to perform over the subscription term. These performance obligations are satisfied over time as the customer simultaneously receives and consumes the benefits. Contracts are typically one year in length, but may be up to five years.

At the beginning of each subscription term we invoice our customers, typically in annual installments but also quarterly and semi-annually. Amounts that have been invoiced for non-cancelable contracts are recorded in accounts receivable and in deferred revenue or revenue. We report revenue net of sales tax and other taxes collected from customers to be remitted to government authorities.

Professional Services and Other

Professional services and other revenue primarily consist of onboarding services and are typically recognized as services are performed since our customers simultaneously receive the benefits of these services as they are performed, which is generally over a period of up to six months from provisioning access to the platform. We invoice our customers for professional services at the outset of the contract. Amounts that have been invoiced for non-cancelable contracts are recorded in accounts receivable and in deferred revenue or revenue. We report revenue net of sales tax and other taxes collected from customers to be remitted to government authorities.

Contract Balances

Contract Assets

A contract asset is the right to consideration for transferred goods or services when the amount is conditioned on something other than the passage of time. These balances are included in prepaid expenses and other current assets on our consolidated balance sheets.

Deferred Revenue

We record deferred revenue when we have an unconditional right to payments in advance of satisfying the performance obligations on our contracts. The balance consists primarily of annual plan subscription services and professional services not
yet provided as of the balance sheet date. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as a current liability in our consolidated balance sheets. The deferred revenue balance does not represent the total contract value of annual or multi-year, non-cancelable agreements.

Deferred Contract Costs

We capitalize costs of obtaining revenue contracts that are incremental and recoverable. Incremental costs primarily include sales commissions and bonuses for new and renewal revenue contracts and associated payroll tax and fringe benefit costs and are recorded within deferred contract costs on the consolidated balance sheets. Capitalized amounts are recoverable through future revenue streams under all customer contracts.

Contract costs are amortized on a straight-line basis up to four years, which reflects the expected period of benefit of the performance obligation and may be longer than the initial contract period. We determined the estimated benefit period having considered both qualitative and quantitative factors, including the length of the subscription terms in our customer contracts and the anticipated life of our technology, among other such factors. Deferred contract costs related to renewals are amortized over the renewal term which is generally one year to three years. Amortization of contract costs are classified within operating expenses based on the function of the underlying employee receiving the benefit in the accompanying consolidated statements of operations.

Deferred contract costs are periodically analyzed for impairment. As of January 31, 2023 and 2022, we have not identified any potential indicators of impairment.

Cost of Revenue

Cost of revenue consists of expenses related to providing platform access to customers and onboarding services. These costs include payments to third-party cloud infrastructure providers for hosting software solutions and costs associated with application service providers utilized to deliver the platform, allocated personnel-related costs, including salaries, cash-based performance compensation, benefits and stock-based compensation, overhead cost allocations related to facilities and shared IT-related expenses, including depreciation expense and amortization of internal use software.

Operating Expenses

Operating expenses consist of sales and marketing, research and development, and general and administrative expenses. Personnel costs are the most significant component of operating expenses and consist of salaries, cash performance-based compensation, employee benefits and stock-based compensation. Operating expenses also include overhead cost allocations.

Sales and Marketing

Sales and marketing expenses consist primarily of personnel costs for sales and marketing organization, costs related to sponsorships, events and advertising, agency costs, travel-related expenses, and allocated overhead costs. Costs associated with our advertising and sales promotions are expensed as incurred. During the fiscal years ended January 31, 2023, 2022, and 2021, we recognized $20.8 million, $12.2 million, and $8.1 million, respectively, in advertising costs, which included brand and sponsorship costs.

Research and Development

Research and development expenses consist primarily of personnel costs for engineering, service, design, and information technology teams. Additionally, research and development expenses include allocated overhead costs and contractor fees. Research and development costs are expensed as incurred. Capitalized internal-use software development costs are excluded from research and development expenses as they are capitalized as a component of property and equipment, net and amortized to cost of revenue over the software’s expected useful life, which is generally three years.

General and Administrative

General and administrative expenses consist primarily of personnel costs for finance, legal, human resources and other administrative functions, as well as outside professional services. In addition, general and administrative expense includes non-personnel costs, such as legal, accounting and other professional fees, software costs, certain tax, license and insurance-related expenses and allocated overhead costs.

Stock-Based Compensation
We measure and record the expense related to stock-based payment awards based on the fair value of those awards as determined on the date of grant. We recognize stock-based compensation expense over the requisite service period of the individual grant, generally equal to the vesting period, and use the straight-line method to recognize stock-based compensation. We use the Black-Scholes-Merton (“Black-Scholes”) option pricing model to determine the fair value of stock based awards.

We estimate expected forfeitures of stock-based awards at the grant date and recognize compensation cost only for those awards expected to vest. We estimate our forfeitures rate based on an analysis of our actual historical forfeitures materializing in the previous fiscal years, and revise the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. We routinely evaluate the appropriateness of the forfeiture rate based on actual forfeiture experience, analysis of employee turnover and expectations of future option exercise behavior.

We calculate the fair value of options granted by using the Black-Scholes option-pricing model with the following assumptions:

Expected Volatility

We estimate volatility for option grants by evaluating the average historical volatility of a peer group of companies for the period immediately preceding the option grant for a term that is approximately equal to the options’ expected term since we do not have sufficient trading history of our common stock.

Expected Term

The expected term of our stock options represents the period that the stock-based awards are expected to be outstanding. We have elected to use the simplified method to compute the expected term, which we believe is representative of future behavior. Our stock plans provide a contractual term of ten years before the option is forfeited.

Risk-Free Interest Rate

The risk-free interest rate is based on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent term of the expected life of the option on the grant date.

Dividend Yield

We have not declared or paid dividends to date and do not anticipate declaring dividends in the foreseeable future. As such, the dividend yield has been estimated to be zero.

Fair Value of Common Stock

Prior to our IPO, the fair value of the common stock underlying the stock option awards was determined by the board of directors (“the Board”). Given the absence of a public trading market, the Board considered numerous objective and subjective factors to determine the fair value of our common stock at each meeting at which awards were approved. These factors included, but were not limited to, (i) contemporaneous third party valuations of our common stock; (ii) the rights, preferences, and privileges of our convertible preferred stock relative to our common stock; (iii) the lack of marketability of our common stock; (iv) stage and development of our business; (v) general economic conditions; and (vi) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. To evaluate the fair value of the underlying shares for grants between two independent valuations and after the last independent valuation, a linear interpolation framework was used to evaluate.

Subsequent to our IPO, the fair value of each share of underlying common stock is based on the closing price of our Class A common stock as reported on the Nasdaq Stock Market on the date of grant.

Investment Income

Investment income consists primarily of income earned on our investments, cash and cash equivalents and restricted cash.

Other Income (Expense), Net

Other income (expense), net, is primarily comprised of realized and unrealized foreign currency gains and losses.

Leases
We determine if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether we have the right to control the identified asset. Right-of-use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the lease term. ROU assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable.

As the implicit rate in our leases is generally unknown, we use the incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The lease terms may include options to extend or terminate the lease when it is reasonably certain we will exercise any such options. Lease costs for our operating leases are recognized on a straight-line basis over the lease term. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease term. The interest component of finance leases is included in interest expense and recognized using the effective interest method over the lease term. We did not have any finance leases in the periods presented.

We have elected to not separate lease and non-lease components for any leases within our existing classes of assets and, as a result, we account for any lease and non-lease components as a single lease component. We have also elected to not apply the recognition requirement to any leases within our existing classes of assets with a term of 12 months or less (short-term leases). Variable lease costs are comprised primarily of our proportionate share of operating expenses, property taxes, and insurance and is classified as lease cost due to our election to not separate lease and non-lease components.

Operating leases are included in operating lease right-of-use assets, current operating lease liabilities, and non-current in our consolidated balance sheets. Refer to Note 14. Leases, for further information.

Income Taxes

We account for income taxes using the asset and liability method. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.

In evaluating our ability to recover our deferred income tax assets, we consider all available positive and negative evidence, using a more likely than not standard. The evaluation considers our recent historical operating results, ongoing tax planning, and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. In the event we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance that would reduce the provision for income taxes. Conversely, in the event that all or part of the net deferred tax assets are determined not to be realizable in the future, we would charge an adjustment to the valuation allowance to earnings in the period when such determination is made. As of January 31, 2023, we recorded a full valuation allowance in jurisdictions where we had net deferred tax assets, which consist of net operating loss carryforwards and other basis differences, as we have concluded that it is more likely than not that our deferred tax assets will not be realized.

We recognize tax expense associated with Global Intangible Low-Taxed Income as it is incurred as part of the current income taxes to be paid or refunded for the current period.

We recognize the tax benefits on any uncertain tax positions taken or expected to be taken in the consolidated financial statements when it is more likely than not the position will be realized upon ultimate settlement with tax authorities, assuming full knowledge of the position and relevant facts. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

Recently Adopted Accounting Pronouncements

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), (“ASC 842”) and issued certain transitional guidance and subsequent amendments between January 2018 and February 2020 within ASU No. 2017-13, ASU No. 2018-01, ASU No. 2018-10, ASU No. 2018-11, ASU No. 2018-20, ASU No. 2019-01, ASU No. 2019-10, ASU No. 2020-02, and ASU No. 2020-05 (collectively, “Topic 842”). The guidance in Topic 842 supersedes the leasing guidance in Topic 840, Leases. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for all leases with terms longer than twelve months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the consolidated statements of operations. Per ASU No. 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842): Effective Dates for Certain Entities, issued June 2020, Topic 842, as amended, is effective for fiscal years beginning after
December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Topic 842 is effective for our fiscal year ending January 31, 2022 and interim periods beginning February 1, 2023 with early adoption permitted. While we previously elected to take advantage of the extended transition period available to emerging growth companies for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended, we decided to early adopt Topic 842. We adopted this standard under the modified-retrospective approach, using the practical expedients allowing us to not reassess (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification for any expired leases, and (iii) indirect costs for any existing leases. Additionally, any lease arrangements with a term of 12 months or less will be recognized on the consolidated statements of operations on a straight-line basis over the lease term and any non-lease components shall not be separated from the lease components, but instead accounted for as a single lease component. Upon adoption of ASC 842, we recognized a right-of-use asset of $59.6 million and a lease liability of $61.3 million at February 1, 2022 on our consolidated balance sheets. Prior period amounts were not restated and are reported in accordance with ASC 840. Refer to Note 14. Leases, for further information.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement on Credit Losses on Financial Instruments, and issued subsequent amendments to the initial guidance and transitional guidance between November 2018 and February 2020 within ASU No. 2018-19, ASU No. 2019-04, ASU No. 2019-05, ASU No. 2019-10, ASU No. 2019-11 and ASU No. 2020-02 (collectively, “Topic 326”). Topic 326 introduces new guidance for credit losses on instruments within its scope. The new guidance introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade and other receivables, held-to-maturity debt securities, loans and net investments in leases. The new guidance also modifies the impairment model for available-for-sale debt securities and requires entities to determine whether all or a portion of the unrealized loss on an available-for-sale debt security is a credit loss. Further, the new guidance indicates that entities may not use the length of time a security has been in an unrealized loss position as a factor in concluding whether a credit loss exists. Per ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842), Topic 326, as amended, is effective for (1) public business entities that meet the definition of an SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and (2) all other entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Topic 326 is effective for our fiscal year beginning February 1, 2023 and early adoption is permitted. While we previously elected to take advantage of the extended transition period available to emerging growth companies for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended, we decided to early adopt Topic 326. We determined that the adoption of this ASU did not have a material impact on our consolidated financial statements. As such, we adopted this ASU prospectively on February 1, 2022.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (Topic 740) (“Topic 740”), which removes certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. For public companies, the guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. We adopted ASU 2019-12 on February 1, 2022 and determined that the adoption of this ASU had no material impact on our consolidated financial statements.
In October 2020, FASB issued ASU No. 2020-10, Codification Improvements (“ASU 2020-10”). The amendments in this guidance affect a wide variety of topics in the ASC by either clarifying the codification or correcting unintended application of guidance. The changes are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. For public companies, the guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. We adopted ASU 2020-10 prospectively on February 1, 2022 and determined that this ASU does not have a material impact on our consolidated financial statements.
v3.23.1
Revenue from Contracts with Customers
12 Months Ended
Jan. 31, 2023
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers Revenue from Contracts with Customers
Disaggregated Revenue Streams

The following disaggregation depicts the nature, amount, timing and uncertainty of cash flows related to the primary types of revenue from contracts with customers.
The following table presents total revenue by type (in thousands):

Fiscal Year Ended January 31,
202320222021
Subscription$338,351 $221,664 $141,068 
Professional services and other17,075 16,371 9,123 
Total$355,426 $238,035 $150,191 

The following table presents total revenue by geography (in thousands):

Fiscal Year Ended January 31,
202320222021
United States$204,931 $142,640 $90,523 
International150,495 95,395 59,668 
Total$355,426 $238,035 $150,191 

Revenue by geography is determined based on the location of our users. Other than the United States, no other individual country accounted for 10% or more of total revenue for any of the periods presented.

Unbilled Accounts Receivable

Unbilled accounts receivable included in trade accounts receivable, net, which generally arise from our contractual right to bill our customers in advance of services on the contract effective date, were $1.0 million and $2.2 million as of January 31, 2023 and January 31, 2022, respectively.

Contract Balances

Contract Assets

Contract assets as of January 31, 2023 and January 31, 2022 were $0.8 million and $0.8 million, respectively. The change in contract assets for all periods presented primarily reflects revenue recognized in excess of billings partially offset by contract assets earned during the period.

Deferred Revenue

The change in deferred revenue for all periods presented primarily reflects cash payments received during the period for which the performance obligation was not satisfied prior to the end of the period, partially offset by revenues recognized during the period. Revenue recognized during the fiscal year ended January 31, 2023, 2022, and 2021 from amounts included in deferred revenue at the beginning of each respective period was $126.1 million, $74.6 million, and $51.2 million, respectively.
Credit Losses

The following table presents a reconciliation of the allowance for credit losses on accounts receivable (in thousands):

Allowance for Credit Losses
Balance at January 31, 2022
$743 
Reserve:
Credit losses808 
Deferred revenue1,667 
Write-offs(1,746)
Recoveries141 
Balance at January 31, 2023
$1,613 

Remaining Performance Obligations

The transaction price allocated to remaining performance obligations represents amounts under non-cancelable contracts expected to be recognized as revenue in future periods, and may be influenced by several factors, including seasonality, the timing of renewals, the timing of service delivery and contract terms. Unbilled portions of the remaining performance obligations are subject to future economic risks including bankruptcies, regulatory changes and other market factors.

The following table presents remaining performance obligations as of the dates indicated below (in millions):

TotalLess than 1 Year1-5 Years
January 31, 2022$373.6 $237.8 $135.8 
April 30, 2022390.9 255.1 135.8 
July 31, 2022410.5 274.2 136.3 
October 31, 2022408.7 283.3 125.4 
January 31, 2023455.7 312.6 143.1 
v3.23.1
Variable Interest Entity and Redeemable Non-Controlling Interest
12 Months Ended
Jan. 31, 2023
Noncontrolling Interest [Abstract]  
Variable Interest Entity and Redeemable Non-Controlling Interest Variable Interest Entity and Redeemable Non-Controlling Interest
On September 14, 2020, we, along with Japan Cloud Computing Co., Ltd., and M30 LLC, (the “Investors”), entered into an agreement, whereby each Investor agreed to purchase shares of common stock of Braze KK (“Braze KK Shares”) for a total purchase price of $10.0 million in two tranches of $5.0 million per tranche in September 2020 and September 2021, to engage in the investment, organization, management and operation of Braze KK focused on the distribution of our products in Japan. The purpose of this arrangement was to further expand our business in the Japanese market.

In March 2022, we consented to the issuance of stock options to purchase Braze KK Shares by certain employees of Braze KK. These options will vest in full in March 2027 and, other than the options held by one officer of Braze KK, cannot be exercised by the holders thereof prior to the exercise of the call or put options described in more detail below. The Company considers the stock options to be a substantive class of equity, classified as a liability within Other long-term liabilities on the consolidated balance sheets. As of January 31, 2023, the liability balance was $0.3 million. The issuance of stock options does not impact our majority stake in Braze KK, as none of the vesting criteria of the options were met as of the balance sheet date. The issuance of stock options did not result in a reconsideration event and therefore Braze KK still met the criteria of a VIE as Braze KK did not have sufficient equity at risk to finance their activities. As a result, we continue to operate Braze KK as a subsidiary, exposing us to business and foreign exchange risk. We consolidate Braze KK and present the results within our consolidated balance sheets, consolidated statements of operations, and consolidated statements of cash flows.

The common stock held by the Investors is callable by us or puttable by the Investors upon certain contingent events. Should the call or put option be exercised, the redemption value would be determined based on a prescribed formula derived from the discrete revenues of Braze KK and the Company and may be settled, at our discretion, with our stock or cash. The non-controlling interest in Braze KK is classified in mezzanine equity as redeemable non-controlling interest as a result of the put right available to the Investors in the future, an event that is not solely in our control. The non-controlling interest is not accreted to redemption value because it is currently not probable that the non-controlling interest will become redeemable.
The following table summarizes the activity in the redeemable non-controlling interests for the periods indicated below (in thousands):

Balance as of January 31, 2021
$2,233
Investment in redeemable non-controlling interest2,450
Net loss attributable to redeemable non-controlling interest(1,448)
Balance as of January 31, 2022
$3,235
Net loss attributable to redeemable non-controlling interest(1,780)
Balance as of January 31, 2023
$1,455
The total combined VIE assets, which represent the maximum exposure to loss, and liabilities were as follows (in thousands):
January 31,
20232022
Assets:
Cash and cash equivalents$4,849 $6,705 
Accounts receivable, net of allowance535 143 
Prepaid expenses and other current assets331 196 
Total current assets5,715 7,044 
Property and equipment, net84 38 
Deferred contract costs902 609 
Other assets29 32 
Total assets$6,730 $7,723 
Liabilities:
Accounts payable$67 $106 
Accrued expenses and other current liabilities2,793 829 
Deferred revenue1,918 725 
Total liabilities4,778 1,660 
Other long-term liabilities322 — 
Total liabilities$5,100 $1,660 
v3.23.1
Prepaid Expenses and Other Current Assets
12 Months Ended
Jan. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses and Other Current Assets Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consist of the following (in thousands):
January 31,
20232022
Prepaid software subscriptions$12,574 $19,396 
Prepaid advertising1,322 704 
Prepaid insurance2,795 4,372 
Investment interest receivable2,013 259 
Consumption tax receivable1,045 667 
Prepaid employee bonuses538 332 
Prepaid employee benefits811 233 
Other5,065 3,625 
Total prepaid expenses and other current assets$26,163 $29,588 
v3.23.1
Fair Value Measurements
12 Months Ended
Jan. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The following table sets forth our financial instruments that were measured at fair value on a recurring basis at the periods indicated below, by level within the fair value hierarchy (in thousands):
January 31, 2023
Level 1Level 2Level 3Total
Cash equivalents
Money market funds$30,873 $— $— $30,873 
30,873 — — 30,873 
Marketable securities
U.S. government securities$307,744 $— $— $307,744 
Foreign bonds— 2,967 — 2,967 
Corporate debt securities— 99,372 — 99,372 
Total marketable securities307,744 102,339 — 410,083 
Total$338,617 $102,339 $— $440,956 
January 31, 2022
Level 1Level 2Level 3Total
Cash equivalents
Money market funds$439,627 $— $— $439,627 
439,627 — — 439,627 
Marketable securities
U.S. government bonds$4,006 $— $— $4,006 
Foreign bonds— 3,203 — 3,203 
Commercial paper— 18,993 — 18,993 
Corporate debt securities— 3,020 — 3,020 
Asset-backed securities— 5,934 — 5,934 
Total marketable securities4,006 31,150 — 35,156 
Total$443,633 $31,150 $— $474,783 

Our money market funds are classified as Level 1 within the fair value hierarchy, because they are valued using quoted prices in active markets as of January 31, 2023 and January 31, 2022. Financial instruments classified as Level 2 within our fair value hierarchy are valued on the basis of prices from an orderly transaction between market participants provided by reputable dealers or pricing services. Prices of these securities are obtained through independent, third-party pricing services and include market quotations that may include both observable and unobservable inputs. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrices and market transactions in comparable investments and various relationships between investments. There were no transfers of financial instruments among Level 1, Level 2, and Level 3 during the periods presented.
v3.23.1
Marketable Securities
12 Months Ended
Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities Marketable Securities
Marketable securities consist of the following for the periods presented (in thousands):

January 31, 2023
Cost or Amortized CostGross Unrealized GainsGross Unrealized LossesTotal Estimated Fair Value
U.S. government securities$312,044 $31 $(4,331)$307,744 
Foreign bonds3,028 — (61)2,967 
Corporate debt securities100,589 27 (1,244)99,372 
Total$415,661 $58 $(5,636)$410,083 

January 31, 2022
Cost or Amortized CostGross Unrealized GainsGross Unrealized LossesTotal Estimated Fair Value
U.S. government bonds$4,021 $— $(15)$4,006 
Foreign bonds3,203 — — 3,203 
Commercial paper18,993 — — 18,993 
Corporate debt securities3,025 — (5)3,020 
Asset-backed securities5,941 — (7)5,934 
Total$35,183 $— $(27)$35,156 
Accrued interest receivables related to our available-for-sale securities of $2.0 million as of January 31, 2023 and $0.3 million as of January 31, 2022 were included within prepaid expenses and other current assets on our consolidated balance sheets.

The Company’s short-term investments consist of available-for-sale debt securities. The weighted-average remaining maturity of the Company’s investment portfolio was less than one year as of the periods presented. No individual security incurred continuous unrealized losses for greater than 12 months.
The Company purchases investment grade marketable debt securities which are rated by nationally recognized statistical credit rating organizations in accordance with its investment policy. This policy is designed to minimize the Company's exposure to credit losses. As of January 31, 2023, the credit-quality of the Company’s marketable available-for-sale debt securities had remained stable. The unrealized losses recognized on marketable available-for-sale debt securities as of January 31, 2023 was primarily related to the continued market volatility associated with market expectations of interest rate increases by the Federal Reserve. The contractual terms of these investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments and it is not expected that the investments would be settled at a price less than their amortized cost basis. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis. The Company is not aware of any specific event or circumstance that would require the Company to change its assessment of credit losses for any marketable available-for-sale debt security as of January 31, 2023. These estimates may change, as new events occur and additional information is obtained, and will be recognized on the consolidated financial statements as soon as they become known. No credit losses were recognized as of January 31, 2023 for the Company’s marketable debt securities.

The contractual maturities of the investments classified as available-for-sale marketable securities are as follows (in thousands):

January 31, 2023
Amortized CostEstimated Fair Value
Due within 1 year$247,214 $244,280 
Due in 1 year through 5 years168,447 165,803 
Total$415,661 $410,083 

January 31, 2022
Amortized CostEstimated Fair Value
Due within 1 year$33,671 $33,646 
Due in 1 year through 5 years1,512 1,510 
Total$35,183 $35,156 

Investment Income

Investment income consists of interest income and accretion income/amortization expense on our cash, cash equivalents, and marketable securities. Investment income is included within other income (expense), net on the consolidated statements of operations. The components of investment income were as follows (in thousands):
Fiscal Year Ended January 31,
202320222021
Interest income$7,393 $506 $1,185 
Amortization of discount/premium, net1,336 (369)(345)
Investment income$8,729 $137 $840 
v3.23.1
Property and Equipment, Net
12 Months Ended
Jan. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net Property and Equipment, Net
Property and equipment, net, consist of the following (in thousands):
January 31,
20232022
Capitalized internal-use software$7,344 $5,353 
Computer equipment, office equipment, and software8,111 3,833 
Leasehold improvements9,410 2,470 
Furniture and fixtures4,085 966 
Total property and equipment28,950 12,622 
Less: accumulated depreciation and amortization(8,611)(5,229)
Total property and equipment, net$20,339 $7,393 
The total depreciation expense and amortization expense for property and equipment was $3.4 million, $2.8 million and $1.6 million, during the fiscal years ended January 31, 2023, 2022 and 2021, respectively. During the fiscal year ended January 31, 2023, the Company removed $1.2 million of fixed assets substantially consisting of leasehold improvements and computer equipment, office equipment, and software, that was fully depreciated from property and equipment, gross and accumulated depreciation, which had no net impact on the Company’s financial results.

We capitalized internal-use software of $2.0 million, $2.4 million and $2.1 million during the fiscal years ended January 31, 2023, 2022, and 2021 respectively. Amortization for capitalized internal-use software costs recognized within cost of revenue on the consolidated statements of operations was $1.7 million, $1.2 million and $0.5 million for the fiscal years ended January 31, 2023, 2022, and 2021, respectively.
v3.23.1
Accrued Expenses and Other Current Liabilities
12 Months Ended
Jan. 31, 2023
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consists of the following (in thousands):
January 31,
20232022
Accrued compensation costs$12,644 $14,075 
Accrued software subscriptions8,454 3,217 
Accrued commissions6,205 5,961 
Accrued professional service fees1,779 2,218 
Accrued advertising922 660 
Accrued tax liability2,152 1,951 
Other5,259 3,541 
Total accrued expenses and other current liabilities$37,415 $31,623 
v3.23.1
Employee Benefit Plans
12 Months Ended
Jan. 31, 2023
Retirement Benefits [Abstract]  
Employee Benefit Plans Employee Benefit PlansWe sponsor a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) plan are discretionary. Matching contributions under the plan were $4.7 million, $2.4 million, and $1.5 million for the fiscal years ended January 31, 2023, 2022, and 2021 respectively.
v3.23.1
Stockholders' Equity (Deficit)
12 Months Ended
Jan. 31, 2023
Equity [Abstract]  
Stockholders' Equity (Deficit) Stockholders’ Equity (Deficit)
Class A and Class B Common Stock

The Company has two classes of common stock, Class A and Class B. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to ten votes and may be converted at the option of the holder into one share of Class A common stock. In addition, all shares of Class B common stock will automatically convert into shares of Class A common stock in certain circumstances, including on the earlier of (i) the last
trading day of the fiscal quarter during which the number of shares of Class B common stock then outstanding represents less than 10% of the aggregate number of shares of Class A common stock and Class B common stock then outstanding, or (ii) the last trading day of the fiscal quarter immediately following the fifth anniversary of the initial public offering. All shares of the Company’s capital stock outstanding immediately prior to our initial public offering, including all shares held by its executive officers, directors, and their respective affiliates, and all shares issuable upon the conversion of our then outstanding convertible preferred stock, were reclassified into shares of Class B common stock immediately prior to the completion of the initial public offering.

Charitable Contributions

In connection with our Pledge 1% commitment, we donated 96,465 shares of our Class A common stock to a charitable donor-advised fund that resulted in the recognition of $4.3 million expense within general and administrative in our consolidated statements of operations during the fiscal year ended January 31, 2023. No stock donations were made during the fiscal years ended January 31, 2022 and 2021.
v3.23.1
Employee Stock Plans
12 Months Ended
Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Employee Stock Plans Employee Stock Plans
We have historically issued equity awards under our Amended and Restated 2011 Equity Incentive Plan (the “2011 Plan”) and our 2021 Equity Incentive Plan (the “2021 Plan”).

Amended and Restated 2011 Equity Incentive Plan

Our 2011 Plan provides for the award of stock options and restricted stock units (“RSUs”) to employees, officers, directors, advisors and other service providers of Braze. The terms of each award and the exercise price of awards under the 2011 Plan are determined by our board of directors. Following effectiveness of the 2021 Plan in connection with our initial public offering, no further awards were made under the 2011 Plan.

2021 Equity Incentive Plan

In November 2021, our board of directors and our stockholders approved the 2021 Plan, which became effective on November 16, 2021. No grants were made under the 2021 Plan prior to its effectiveness. No further grants will be made under the 2011 Plan. At effectiveness, we reserved 25,660,249 shares of our Class A common stock to be issued under the 2021 Plan. In addition, the number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, beginning on February 1, 2022 and continuing through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by the Board no later than the February 1 increase. On February 1, 2022, the number of shares of our Class A common stock reserved for issuance under our 2021 Plan increased by an additional 4,648,401 shares.

Stock Options

A summary of stock option activity for the periods presented, is as follows:
Options Outstanding
Number of OptionsWeighted Average Exercise PriceAverage Remaining Contractual Life (Years)Aggregate Intrinsic Value
(in thousands)
Balance as of January 31, 2021
11,186,400$3.587.99$351,321
Granted3,120,51635.02
Exercised(2,855,522)2.94
Forfeited(415,690)5.48
Balance as of January 31, 2022
11,035,704$12.567.69$413,384
Grantedn/a
Exercised(2,155,929)3.94
Forfeited(707,834)19.13
Balance as of January 31, 2023
8,171,941$14.276.58$153,237
Vested and expected to vest as of January 31, 2023
7,861,331$13.666.52$151,740
Exercisable - January 31, 2023
4,916,568$6.835.72$125,404
Fiscal Year Ended January 31,
202320222021
Weighted-average grant date fair value per share of options granted during each respective periodn/a$24.53$7.41
Aggregate intrinsic value of options exercised during each respective period (in thousands)$71.16$121.90$78.90

We estimate the fair value of stock options using the Black-Scholes option-pricing model on the date of grant. The assumptions used in the Black-Scholes option-pricing model were as follows:

Fiscal Year Ended January 31,
202320222021
Dividend yield (in percentage)n/a—%—%
Expected volatility (in percentage)n/a
61.8 - 66.1%
55.7 - 62.5%
Expected term (in years)n/a
5.9 - 6.7
5.5 - 6.1
Risk-free interest rate (in percentage)n/a
1.0 - 1.2%
0.3 - 1.5%
Fair value of common stockn/a
$65.00
$5.28 - $28.35
Restricted Stock Units

The following table summarizes unvested RSU award activity and related information:

SharesWeighted-Average Grant Date Fair Value
Balance as of January 31, 2022
1,355,065
Granted4,430,554$37.11
Vested(630,851)$48.51
Forfeited(529,250)$45.29
Balance as of January 31, 2023
4,625,518

RSUs granted during the fiscal year ended January 31, 2023 contained a service-based vesting condition of up to approximately a four year period. RSUs typically vest on a quarterly basis or have a one year cliff vesting period with quarterly vesting thereafter.

Employee Stock Purchase Plan

In November 2021, our board of directors and our stockholders approved our employee stock purchase plan (the “ESPP”), which became effective on November 16, 2021. Following completion of our initial public offering, the ESPP authorized the issuance of 1,825,000 shares of our Class A common stock under purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, beginning on February 1, 2022 and continuing through February 1, 2031, by the lesser of (i) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (ii) 2,737,000 shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (i) and (ii) above. On February 1, 2022, the number of shares of our Class A common stock reserved for issuance under our ESPP increased by an additional 929,680 shares.

The ESPP is implemented through a series of offerings under which eligible employees are granted purchase rights to purchase shares of the Company’s Class A common stock on specified dates during such offerings. Under the ESPP, our board of directors will be permitted to specify offerings with durations of not more than 27 months, and may specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of our Class A common stock will be purchased for employees participating in the offering. On each purchase date, eligible employees will purchase the shares at a price per share equal to 85% of the lesser of (1) the fair market value of the Company’s Class A common stock on the first trading day of the offering period or (2) the fair market value of the Company’s Class A common stock on the last day of the offering period, as defined by the ESPP.
The Company recognized $1.8 million of stock-based compensation expense related to the ESPP during the fiscal year ended January 31, 2023. As of January 31, 2023, $0.3 million has been withheld on behalf of our employees for a future purchase and is classified as accrued expenses and other current liabilities on the consolidated balance sheets.

During the fiscal year ended January 31, 2023, the Company issued 125,276 shares of Class A common stock under the ESPP. As of January 31, 2023, 2,629,404 shares of Class A common stock remain available for issuance under the ESPP.

Stock-based Compensation Expense

The following table summarizes stock-based compensation expense, which was included in the consolidated statements of operations as follows (in thousands):

Fiscal Year Ended January 31,
202320222021
Cost of revenue$3,616 $2,185 $650 
Sales and marketing23,871 16,281 2,892 
Research and development28,897 15,613 2,102 
General and administrative15,833 13,101 1,896 
Stock-based compensation, net of amounts capitalized$72,217 $47,180 $7,540 
Capitalized stock-based compensation expense1,121 387 126 
Total stock-based compensation expense$73,338 $47,567 $7,666 

As of January 31, 2023, total compensation cost not yet recognized related to unvested equity awards and the weighted-average remaining period over which these costs are expected to be realized were as follows:

Stock OptionsRSUs
Unrecognized compensation costs (in thousands)$44,170$114,730
Weighted-average remaining recognition period (years)2.472.96

Secondary Transaction
In March 2021, certain existing investors entered into an arms-length transaction to purchase 292,486 shares of our common stock from certain of our current employees (the “2021 Secondary Transaction”). The purchase price paid was in excess of the fair value of the common stock on the purchase date. In connection with the 2021 Secondary Transaction, we recognized $3.0 million of stock-based compensation expense which represented the amounts paid above fair value of common stock. The expense is included in the same financial statement line items as the employees’ other compensation. No secondary transactions involving employees occurred during the fiscal year ended January 31, 2023
v3.23.1
Commitments and Contingencies
12 Months Ended
Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Indirect Taxes

We are subject to indirect taxation in some, but not all, of the various U.S. states and foreign jurisdictions in which we conduct business. Therefore, we have an obligation to charge, collect and remit Value Added Tax (“VAT”) or Goods and Services Tax (“GST”) in connection with certain of our foreign sales transactions and sales and use tax in connection with eligible sales to subscribers in certain U.S. states. On June 21, 2018, the U.S. Supreme Court issued an opinion in South Dakota v. Wayfair. The State of South Dakota alleged that U.S. constitutional law should be revised to permit South Dakota to require remote sellers to collect and remit sales tax in South Dakota in accordance with South Dakota’s sales tax statute. Under the U.S. Supreme Court’s ruling, the longstanding Quill Corp v. North Dakota sales tax case was overruled, and states may now require remote sellers to collect sales tax under certain circumstances. We began collecting sales tax in relevant jurisdictions for the fiscal year ended January 31, 2019. As a result of this ruling and given the scope of our operations, taxing authorities continue to provide regulations that increase the complexity and risks to comply with such laws and could result in substantial liabilities, prospectively as well as retrospectively. Based on the information available, we continue to evaluate and assess the jurisdictions in which indirect tax nexus exists and believe that the indirect tax liabilities are adequate and reasonable. Due to the complexity and uncertainty around the application of these rules by taxing authorities, results may vary materially from expectations, and we have recognized liabilities for contingencies related to state sales and use tax, VAT, and GST deemed probable and estimable totaling $0.5 million and $1.3 million as of January 31, 2023 and 2022, respectively, which is included in other
current liabilities on the consolidated balance sheets. As of fiscal year ended January 31, 2023, we have remediated potential exposure in several jurisdictions due to not filing prior returns, and the Company continues to evaluate the potential exposure on an ongoing basis.

Legal Contingencies

From time to time, in the ordinary course of business, we are or may be involved in various legal or regulatory proceedings, claims or purported class actions related to, among other things, alleged infringement of third-party patents and other intellectual property rights, commercial, labor and employment, wage and hour and other claims. We have been, and may in the future be, put on notice or sued by third-parties for alleged infringement of their proprietary rights, including patent infringement. We accrue a liability when we believe that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. We believe we have recorded adequate provisions for any such matters and, as of January 31, 2023, we believe that no material loss will be incurred in excess of the amounts recognized in our financial statements.
v3.23.1
Leases
12 Months Ended
Jan. 31, 2023
Leases [Abstract]  
Leases Leases
The Company’s lease portfolio consists solely of office space with lease terms ranging from less than one to ten years. Certain lease agreements include options to renew or terminate the lease, which are not reasonably certain to be exercised and therefore are not factored into the determination of lease payments.

The following table presents information on our operating leases for the fiscal year ended January 31, 2023 (in thousands):

Fiscal Year Ended January 31, 2023
Operating lease cost$13,638 
Variable lease cost2,521 
Short-term lease cost1,795 
Total net lease cost$17,954

The future maturities of the Company’s operating lease liabilities by fiscal year were as follows (in thousands):

2024$10,705 
202510,621 
20268,318 
20277,351 
20285,932 
Thereafter18,755 
Total future undiscounted lease payments61,682 
Less: imputed interest(10,397)
Less: tenant improvement allowance not yet received— 
Total reported lease liability$51,285 

The Company's lease terms and discount rates are as follows:
January 31, 2023
Weighted-average remaining lease term (years)6.6
Weighted-average discount rate5.5 %

Other information for the Company's leases is as follows (in thousands):
Fiscal Year Ended January 31, 2023
Cash paid for amounts included in the measurement of lease liabilities$10,292 
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities$— 
New York City Headquarters Agreement

In November 2022, the Company entered into a Sublease Agreement (the “Sublease”) pursuant to which the Company agreed to lease approximately 92,300 square feet of general office space in New York, New York. The term of the Sublease commences on October 1, 2023 and will terminate on January 30, 2034. Under the Sublease, the Company's fixed rent obligation is $0.6 million per month, provided, that the Company shall be entitled to a rent abatement in the aggregate amount of $6.6 million to be applied in equal monthly installments until the abatement amount is fully exhausted. The Sublease contains customary provisions for real property subleases of this type, including specified termination rights, and is subject to and contingent upon receipt of a standard third-party consent.

Berlin Lease Agreement
In October 2022, the Company entered into a lease agreement for a new office space in Berlin, Germany. The lease commencement date, which is when the premises will become available to the Company for use, is expected to be in the first quarter of fiscal year 2024. The Company is obligated to pay €0.1 million per month beginning in the second quarter of fiscal year 2024 through the fourth quarter of fiscal 2025, the expiration date.
v3.23.1
Income Taxes
12 Months Ended
Jan. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The components of the provision for (benefit from) income taxes are as follows (in thousands):

Fiscal Year Ended January 31,
202320222021
Current:
Federal$— $— $— 
State and local52 15 26 
Foreign496 (100)451 
Total current548 (85)477 
Deferred:
Federal— — — 
State and local— — — 
Foreign35 (80)60 
Total deferred35 (80)60 
Provision for (benefit from) income taxes$583 $(165)$537 

The components of loss before income taxes are as follows (in thousands):

Fiscal Year Ended January 31,
202320222021
United States$(138,226)$(76,030)$(33,352)
Foreign(1,937)(2,302)1,920 
Loss before provision for income taxes$(140,163)$(78,332)$(31,432)

A reconciliation of the benefit from (provision for) income taxes to the amounts computed by applying the statutory federal income tax rate to earnings before income taxes is shown as follows:
Fiscal Year Ended January 31,
202320222021
Statutory income tax expense21.0 %21.0 %21.0 %
Foreign tax rate differential0.1 %0.8 %0.2 %
State taxes— %— %(0.1)%
Permanent items(0.3)%(3.0)%(2.0)%
Change in valuation allowance(24.2)%(26.5)%(21.6)%
Stock-based compensation1.5 %5.8 %(1.4)%
Tax credits1.5 %2.1 %2.2 %
Effective tax rate(0.4)%0.2 %(1.7)%

Deferred Income Taxes

The tax effects of cumulative temporary differences that give rise to significant deferred tax assets and deferred tax liabilities are presented below (in thousands). The valuation allowance relates to deferred tax assets for which it is more likely than not that the tax benefit will not be realized.
Fiscal Year Ended January 31,
20232022
Deferred tax assets:
Loss carryforwards$72,878 $46,886 
Compensation and benefits16,834 10,772 
Operating lease liabilities12,679 — 
Tax credits5,689 3,541 
Capitalized costs5,568 — 
Other3,999 1,429 
Deferred tax assets117,647 62,628 
Less: valuation allowance(93,150)(52,209)
Deferred tax asset, net of valuation allowance24,497 10,419 
Deferred tax liabilities:
Deferred contract costs(11,826)(10,286)
Property, equipment and software(1,264)(133)
Operating lease right-of-use assets(11,447)— 
Deferred tax liabilities(24,537)(10,419)
Net deferred tax assets/(liabilities)$(40)$— 

As of January 31, 2023, we had NOL carryforwards for federal and state income tax purposes of approximately $281.6 million and $182.4 million, respectively. Under current law, U.S. federal NOLs incurred in tax years beginning after December 31, 2017 may be carried forward indefinitely, but the deductibility of federal NOLs is limited to 80% of taxable income in tax years beginning after December 31, 2020. Accordingly, $242.2 million of our NOLs may be carried forward indefinitely for federal tax purposes and $39.4 million, if not utilized, will expire at various times between 2035 and 2037. The majority of state NOLs if not utilized, will expire at various times between 2026 and 2043. We also had foreign NOL carryforwards as of January 31, 2023 of $8.3 million, the majority of which may be carried forward indefinitely. As of January 31, 2022, we had NOL carryforwards for federal and state income tax purposes of approximately $179.4 million and $119.1 million, respectively.

At January 31, 2023, the Company had tax credit carryforwards of $5.7 million, the majority of which are related to credits for research activities, and if not utilized, will expire between 2037 and 2043.

IRC Sections 382 and 383 place a limitation on the amount of taxable income that can be offset by carryforward tax attributes, such as net operating losses or tax credits, after a change in control. Generally, after a change in control, a loss corporation cannot deduct carryforward tax attributes in excess of the limitation prescribed by Sections 382 and 383. Therefore, certain of our carryforward tax attributes may be subject to an annual limitation regarding their utilization against taxable income in future periods. As a result of issuances of different classes of preferred stock to investors in 2013, 2014 and 2017, we triggered “ownership shifts” as defined in Internal Revenue Code Section 382 and related provisions. These ownership shifts resulted in a reduction of NOLs in the fiscal year ended January 31, 2021 of $13.8 million and credits of $0.7 million. Our utilization of our NOLs and credits is limited by these ownership shifts but those limitations do not have a significant impact to
the financial statements since there is no utilization of the NOLs and credits and a full valuation allowance exists against the net operating losses and credits. Subsequent ownership changes may subject us to additional annual limitations of its net operating losses. Such annual limitation could result in the expiration of the NOLs and credits.

We determine our valuation allowance on deferred tax assets by considering both positive and negative evidence to ascertain whether it is more likely than not that deferred tax assets will be realized. Realization of deferred tax assets is dependent upon the generation of future taxable income, if any, the timing, and amount of which are uncertain. Due to our history of losses, we believe that it is not more likely than not that jurisdictions where we have net deferred tax assets can be realized as of January 31, 2023. Accordingly, we have recorded a full valuation allowance against these respective net deferred tax assets. The valuation allowance increased by $40.9 million, and $22.9 million, during the fiscal years ended January 31, 2023, and 2022, respectively.

The Company has not provided for U.S. federal income and foreign withholding taxes on undistributed earnings from non-U.S. operations as of January 31, 2023 because the Company intends to reinvest such earnings indefinitely outside of the United States. The amount of any unrecognized deferred tax liability related to these earnings would not be material.

A reconciliation of the beginning and ending amount of unrecognized tax benefits, including penalties but excluding interest, is as follows (in thousands):

Fiscal Year Ended January 31,
202320222021
Balance at February 1$647 $902 $647 
Additions for tax positions of prior years— — 902 
Reductions for tax positions of prior years(647)(255)(647)
Balance at January 31$— $647 $902 

The Company recognizes interest and, if applicable, penalties related to unrecognized tax benefits in the income tax provision. As of January 31, 2023, 2022 and 2021, there were no interest and penalties recorded.

As of January 31, 2023, 2022 and 2021, accrued unrecognized tax benefits were $0.0 million, $0.6 million, and $0.9 million, respectively, and if recognized would reduce the provision for income taxes, and our effective tax rate.

We are subject to income tax examinations in the United States and various state and foreign jurisdictions. Our most significant operations are in the United States and the earliest open tax year subject to potential examination is the period ended January 31, 2020. However, amounts reported as NOLs from these prior tax periods also remain subject to review by most tax authorities.
v3.23.1
Net Loss per Share
12 Months Ended
Jan. 31, 2023
Earnings Per Share [Abstract]  
Net Loss per Share Net Loss per Share
We compute net loss per share of our Class A common stock and Class B common stock under the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share in the Company’s net loss. The following table sets forth the computation of basic and diluted net loss per share attributable to Braze, Inc. common stockholders during the periods presented (in thousands, except per share amounts):
Fiscal Year Ended January 31,
202320222021
Numerator:
Net loss attributable to Braze, Inc.$(138,966)$(76,719)$(31,752)
Denominator:
Weighted-average shares of Braze, Inc. common stock outstanding94,597 35,078 18,205 
Less: weighted-average unvested shares of Braze, Inc. subject to repurchase(28)(181)(233)
Weighted-average shares used to calculate net loss per share attributable to Braze, Inc. common stockholders, basic and diluted94,569 34,897 17,972 
Net loss per share attributable to Braze, Inc. common stockholders, basic and diluted$(1.47)$(2.20)$(1.77)
The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per share attributable to Braze, Inc. common stockholders for the periods presented, because their inclusion would be anti-dilutive (in thousands):
Fiscal Year Ended January 31,
202320222021
Convertible preferred stock on an as-converted basis— — 62,831 
Options to purchase common stock8,172 11,036 11,186 
Restricted stock units4,626 1,355 — 
ESPP shares estimated to be purchased121 — — 
Warrants to purchase common stock— — 218 
Total12,919 12,391 74,235 
v3.23.1
Related Party Transactions
12 Months Ended
Jan. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions Related Party TransactionsIn May 2021, the Chief Financial Officer of Datadog, Inc., one of our vendors, joined our board of directors. We have purchased services from Datadog, Inc. in the aggregate amount of approximately $1.4 million during the fiscal year ended January 31, 2023, of which $0.4 million was included within accrued expenses and other current liabilities on the consolidated balance sheets. We have purchased $1.2 million during the fiscal year ended 2022. During the fiscal year ended January 31, 2021, we had no related party transactions.
v3.23.1
Subsequent Events
12 Months Ended
Jan. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
In February 2023, the Company granted RSUs for a total of 148,362 shares of Class A common stock to employees pursuant to the 2021 Plan. The RSUs vest over a service period of approximately four years. The grant date fair value of these awards was $4.9 million.

In March 2023, the Company granted RSUs for a total of 2,914,105 shares of Class A common stock to employees pursuant to the 2021 Plan. The RSUs vest over a service period of approximately three years. The grant date fair value of these awards was $97.5 million.

On March 27, 2023, the Company entered into a definitive stock purchase agreement to acquire all outstanding stock of North Star Y, Pty Ltd (“North Star”) for estimated aggregate closing consideration of $28.0 million in cash and stock. In addition, the sellers in the transaction may also be entitled to certain earn-out payments based on specified commercial targets over two years, in each case subject to customary payment caps. The acquisition is expected to close during the second quarter of fiscal year 2024, subject to customary closing conditions.
v3.23.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Jan. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, and variable interest entities (“VIE”) for which we are the primary beneficiary. Intercompany balances and transactions have been eliminated in consolidation.
Reclassifications
Reclassifications

Certain reclassifications and immaterial changes have been made to prior-period financial statements to conform to the current-period presentation.
Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reported period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Significant items subject to such estimates and assumptions include, but are not limited to, the standalone selling price for separate performance obligations in our revenue arrangements, expected period of benefit for deferred contract costs, the valuation of common stock and stock-based compensation, the allocation of overhead costs between cost of revenue and operating expenses, the estimated useful lives of intangible and depreciable assets, the incremental borrowing rate, the valuation of deferred tax assets and liabilities and other tax estimates including our ability to utilize net operating losses.
Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments as facts and circumstances dictate. As future events and their effects, including the uncertainty surrounding rapidly changing market and economic conditions from the outbreak of COVID-19 or other significant macroeconomic events, cannot be determined with precision, actual results could differ from those estimates and many of our estimates and assumptions have required increased judgement and carry a higher degree of variability and volatility.
Basic and Diluted Net Loss attributable to Braze, Inc. Common Stockholders per Share
Basic and Diluted Net Loss attributable to Braze, Inc. Common Stockholders per Share

Basic and diluted net loss attributable to Braze, Inc. common stockholders per share is presented in conformity with the two-class method required for participating securities. Under the two-class method, net loss is attributed to common stockholders and participating securities based on their participation rights. Prior to our IPO, we considered all series of our convertible preferred stock to be participating securities. Under the two-class method, the net loss attributable to Braze, Inc. common stockholders is not allocated to the convertible preferred stock as the holders of our convertible preferred stock do not have a contractual obligation to share in our losses.

Basic loss attributable to Braze, Inc. per common stockholder’s share is computed by dividing the net loss by the weighted-average number of shares of Braze, Inc. common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss attributable to Braze, Inc. by the weighted-average number of shares of Braze, Inc. common stock together with the number of additional shares of Braze Inc. common stock that would have been outstanding if all potentially dilutive shares of Braze Inc. common stock had been issued. Since we were in a loss position for the periods presented, basic net loss per share attributable to Braze, Inc. common stockholders is the same as diluted net loss per share attributable to Braze, Inc. common stockholders since the effects of potentially dilutive securities are antidilutive.
Segment Reporting
Segment Reporting

Operating segments are defined as components of an entity for which discrete financial information is available that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. Our Chief Executive Officer (“CEO”) is the CODM. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. As such, we have one operating segment, which is the business of cloud-based customer engagement platform subscriptions.
Fair Value of Financial Instruments
Fair Value of Financial Instruments

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The guidance describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value.

Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date

Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities

Level 3 – Unobservable inputs that are supported by little or no market data for the related assets or liabilities

The categorization of a financial instrument within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Our financial instruments include cash equivalents, marketable securities, accounts receivable, accounts payable, and other current assets and liabilities. At January 31, 2023 and 2022, the carrying amounts of accounts receivable, accounts payable, and other current assets and liabilities approximated fair values because of their short-term nature.
Foreign Currency
Foreign Currency

The functional currency of our foreign subsidiaries is the local currency. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the exchange rate on the transaction date. Monetary assets and liabilities denominated in currencies other than the functional currency are remeasured at period-end using the period-end exchange rate. Gains and losses resulting from remeasurement are recorded in other income (expense), net, on the consolidated statements of operations. All assets and liabilities of foreign subsidiaries are translated at the current exchange rate as of the end of the period, retained earnings and other equity items are translated at historical rates, and revenue and expenses are translated at average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into U.S. dollars is reflected as foreign currency cumulative translation adjustments reported on the consolidated statements of comprehensive loss.
Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income (expense), net in the accompanying consolidated statements of operations when realized.
Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents represent cash and highly liquid investments with original contractual maturities of three months or less at the date of purchase. Cash and cash equivalents consist of deposit accounts, interest-bearing money market accounts, and overnight short-term repurchase agreements that are stated at fair value.
Accounts Receivable, Net
Accounts Receivable, Net and Credit Losses

Accounts receivable consists of customer obligations due under normal trade terms and are recorded at amounts billed and unbilled to customers, net of allowance for any potential uncollectible accounts. Unbilled amounts are included in trade accounts receivable, net, which generally arise from our contractual right to bill our customers in advance of services on the contract effective date. Trade accounts receivable are recorded at invoiced amounts and do not bear interest.
We maintain an allowance for credit losses for accounts receivable, net which is recorded as an offset to accounts receivable, net and changes in this allowance are recorded as general and administrative expenses in the consolidated statements of operations. We assess collectability by reviewing accounts receivable on a collective basis when similar characteristics exist and on an individual basis when we identify specific customers with known disputes or collectability issues. In determining the amount of the allowance for credit losses, we consider historical collectability based on past due status and make judgements about the creditworthiness of customers based on ongoing credit evaluations. A receivable is considered past due if we have not received payment based on agreed-upon terms. We also consider customer-specific information, current market conditions, and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss data. No material write-offs of accounts receivable have been recognized in any of the periods presented.
Concentration of Credit Risk
Concentration of Credit Risk

Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, marketable securities, and accounts receivable. Restricted cash consists of letters of credit related to our leased properties. For cash, cash equivalents, restricted cash, and marketable securities, we are exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the consolidated balance sheets in excess of the Federal Deposit Insurance Corporation (“FDIC”) limits. Cash, cash equivalents, restricted cash, and marketable securities balances are maintained at financial institutions that management believes are of high-credit, quality financial institutions, where deposits, at times, exceed the FDIC limits.
Marketable Securities
Marketable Securities

We classify our investments in marketable securities within current assets on the consolidated balance sheets as the investments are available for use, if needed, in current operations as we may sell our marketable securities at any time, without
significant penalty, even if they have not yet reached maturity. These investments are carried at fair value, based on quoted market rates when observable or utilizing data points that are observable, such as quoted prices, interest rates and yield curves. Gains and losses are determined based on the specific identification method and are recognized when realized as a component of Other income, net in our consolidated statements of operations.We review our securities on a regular basis to evaluate if any security has experienced an other-than temporary decline in fair value. We consider an available-for-sale security to be impaired if the fair value of the investment is less than its amortized cost basis, our intent to sell, or whether it is more likely than not that we are required to sell the security before recovery of its amortized cost basis. If we believe that an other-than-temporary decline exists in one of the securities, we will write down these investments to fair value. To the extent that the decline in fair value is related to credit losses, such as changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors, the write-down related to credit loss would be recorded in Other income, net in our consolidated statements of operations. Impairments related to factors other than credit losses are recognized in accumulated other comprehensive income (loss), net of tax. As of January 31, 2023, the Company had not recorded any credit impairments.
Property and Equipment, Net Property and Equipment, NetProperty and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is computed using the straight-line method over the estimated useful life of the related asset. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred. Upon asset retirement or sale, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets, and the resulting gain or loss is reflected in general and administrative expenses in the consolidated statements of operations.
Impairment of Long-Lived Assets Impairment of Long-Lived AssetsLong-lived assets, subject to depreciation and amortization, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of these assets or asset groups may not be recoverable or that the useful life is shorter than originally estimated. Recoverability of these assets or asset groups is measured by comparison of the carrying amount of each asset or asset group to the future undiscounted cash flows the asset or asset group is expected to generate over their remaining lives. If the asset or asset group is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset or asset group. If the useful life is shorter than originally estimated, we amortize the remaining carrying value over the new shorter useful life.
Capitalized Internal-use Software Costs
Capitalized Internal-use Software Costs

We capitalize certain costs incurred to develop new or additional customer-facing software functionality, on the consolidated balance sheets as a component of property and equipment, net. We capitalize qualifying personnel costs, including stock-based compensation, and consulting costs incurred during the application development stage so long as the project is authorized, it is probable the project will be completed, and the software will be used to perform the function intended. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred and included in research and development expenses on the consolidated statements of operations. These capitalized costs are amortized over the software’s expected useful life, which is generally three years, within cost of revenue on the consolidated statements of operations.
Comprehensive Loss
Comprehensive Loss

Our comprehensive loss is currently comprised of unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.
Variable Interest Entity
Variable Interest Entity

A VIE is an entity that either has insufficient equity to permit the entity to finance its activities without additional subordinated financial support or has equity investors who lack the characteristics of a controlling financial interest. The primary beneficiary of a VIE is the party with both the power to direct the activities of the VIE that most significantly impact
the VIE’s economic performance and the obligation to absorb the losses or the right to receive benefits that could potentially be significant to the VIE.

To assess whether we have the power to direct the activities of a VIE that most significantly impact its economic performance, we consider all the facts and circumstances including our role in establishing the VIE and our ongoing rights and responsibilities. This assessment includes identifying the activities that most significantly impact the VIE’s economic performance and identifying which party, if any, has power over those activities. In general, the party that makes the most significant decisions affecting the VIE is determined to have the power to direct the activities of the VIE. To assess whether we have the obligation to absorb the losses or the right to receive benefits that could potentially be significant to the VIE, we consider all of our economic interests, including debt and equity interests, servicing rights and fee arrangements, and any other variable interests in the VIE. If we determine that we are the party with the power to make the most significant decisions affecting the VIE, and we have an obligation to absorb the losses or the right to receive benefits that could potentially be significant to the VIE, then we consolidate the VIE.

We perform ongoing reassessments of whether we are the primary beneficiary of a VIE. The reassessment process considers whether we have acquired or divested the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. We also reconsider whether entities previously determined not to be VIEs have become VIEs, based on new events, and therefore could be subject to the VIE consolidation framework.
Redeemable Noncontrolling Interest
Redeemable Non-controlling Interest

Redeemable non-controlling interests represent the portion of net income (loss), net, and comprehensive income (loss), net, that is not allocable to us, in situations where we consolidate an equity interest or as the primary beneficiary of a VIE for which there are other owners. The amount of non-controlling interest is comprised of the greater of the amount of such interests at the date of the original acquisition of an equity interest in an investment, plus the other shareholders’ share of changes in equity since the date of the investment or estimated redemption value. The resulting changes in the estimated redemption amount (increases or decreases) are recorded with corresponding adjustments against retained earnings or, in the absence of retained earnings, additional paid-in-capital. The redeemable non-controlling interest is classified outside of permanent equity as mezzanine equity on the consolidated balance sheets as the redemption option is outside of our control.
Revenue Recognition
Revenue Recognition

We derive our revenue primarily from subscriptions to our platform, including associated support, and professional services. Our subscriptions do not provide customers with the right to take possession of the software supporting the applications and, as a result, are accounted for as service contracts. Professional services primarily consist of fees for distinct services rendered in training and assisting customers to configure and optimize the use of the platform. Revenue is recognized when control of the promised goods or services is transferred to clients in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We apply the following five-step model to recognize revenue from contracts with clients:

Identification of the contract or contracts with a customer;
Identification of the performance obligation(s) in the contract;
Determination of the transaction price;
Allocation of the transaction price to the performance obligation(s) in the contract; and
Recognition of revenue when, or as, a performance obligation is satisfied.

We identify the performance obligations in a contract or multiple contracts with a customer and determine whether they are distinct or distinct within the context of the contract. When there is more than one distinct performance obligation in a contract, we allocate the transaction price to the performance obligations on a relative standalone selling price basis based on standalone selling prices (“SSP”). We have identified two performance obligations within our contracts with our customers: (i) subscription and (ii) professional services and other.

All contracts generally contain fixed consideration payable upfront by the customer. Some of our multi-year arrangements may contain fixed fees with escalating pricing structures each year. The nature of our subscription performance obligation remains unchanged each period of the arrangement and therefore may create a contract asset reflecting the difference between the amount of revenue recognized compared to the amount billed.

Some of our contracts with customers contain terms, such as service level guarantees, product usage and overage fees, that, along with various potential claims, including breach of warranty, may result in variable consideration. Variable consideration exists when the amount which we expect to receive in a contract is affected by the occurrence or non-occurrence of future events. We develop estimates of variable consideration on the basis of historical information, current trends, and any other specific knowledge about future periods.
Variable consideration is included in the transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Typically, our contracts do not provide customers with any right of return or refund; however, we may make exceptions on a case-by-case basis when it makes commercial sense. Variable consideration, including as a result of service level guarantees, product usage and overage fees or other potential claims such as breach of warranty, was not material during the fiscal years ended January 31, 2023 and 2022. We allocate the variable consideration related to the product usages and overages to the distinct month during which the related services were performed as those fees relate specifically to providing usage of the platform in the period and represents the consideration we are entitled to for the access to the platform. As a result, the usage and overage fees are included in the transaction price and recognized as revenue in the period in which the fee was generated.

To the extent that we grant customers an option to acquire additional products or services, we account for the option as a distinct performance obligation in the contract only if the option provides a material right to the customer that the customer would not receive without entering into the contract. If a material right exists in a contract, revenue allocated to the option is deferred and recognized as revenue only when those future products or services are transferred or when the option expires. Contracts do not typically contain material rights and when they do, the material right has not been significant to our consolidated financial statements.

Once the transaction price is determined, the total transaction price is allocated to each performance obligation in a manner depicting the amount of consideration to which we expect to be entitled in exchange for transferring the products or services to the customer. This allocation is based on the SSP of the products or services included in the arrangement.

Judgment is required to determine the SSP for each performance obligation. We determine SSP based on observable prices for those related goods or services when sold separately, if available. When such observable prices are not available, we determine SSP based on overarching pricing objectives and strategies, taking into consideration market conditions and other factors, including transaction size, product-specific factors, historical sales of the deliverables and costs to deliver the services and applicable margins.

Subscription Services

Subscription revenue is recognized ratably over the contract term beginning on the commencement date of each contract, which is the date the platform is made available to customers. We have determined that subscriptions to our platform represent a stand-ready obligation to perform over the subscription term. These performance obligations are satisfied over time as the customer simultaneously receives and consumes the benefits. Contracts are typically one year in length, but may be up to five years.

At the beginning of each subscription term we invoice our customers, typically in annual installments but also quarterly and semi-annually. Amounts that have been invoiced for non-cancelable contracts are recorded in accounts receivable and in deferred revenue or revenue. We report revenue net of sales tax and other taxes collected from customers to be remitted to government authorities.

Professional Services and Other

Professional services and other revenue primarily consist of onboarding services and are typically recognized as services are performed since our customers simultaneously receive the benefits of these services as they are performed, which is generally over a period of up to six months from provisioning access to the platform. We invoice our customers for professional services at the outset of the contract. Amounts that have been invoiced for non-cancelable contracts are recorded in accounts receivable and in deferred revenue or revenue. We report revenue net of sales tax and other taxes collected from customers to be remitted to government authorities.

Contract Balances

Contract Assets

A contract asset is the right to consideration for transferred goods or services when the amount is conditioned on something other than the passage of time. These balances are included in prepaid expenses and other current assets on our consolidated balance sheets.

Deferred Revenue

We record deferred revenue when we have an unconditional right to payments in advance of satisfying the performance obligations on our contracts. The balance consists primarily of annual plan subscription services and professional services not
yet provided as of the balance sheet date. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as a current liability in our consolidated balance sheets. The deferred revenue balance does not represent the total contract value of annual or multi-year, non-cancelable agreements.

Deferred Contract Costs

We capitalize costs of obtaining revenue contracts that are incremental and recoverable. Incremental costs primarily include sales commissions and bonuses for new and renewal revenue contracts and associated payroll tax and fringe benefit costs and are recorded within deferred contract costs on the consolidated balance sheets. Capitalized amounts are recoverable through future revenue streams under all customer contracts.

Contract costs are amortized on a straight-line basis up to four years, which reflects the expected period of benefit of the performance obligation and may be longer than the initial contract period. We determined the estimated benefit period having considered both qualitative and quantitative factors, including the length of the subscription terms in our customer contracts and the anticipated life of our technology, among other such factors. Deferred contract costs related to renewals are amortized over the renewal term which is generally one year to three years. Amortization of contract costs are classified within operating expenses based on the function of the underlying employee receiving the benefit in the accompanying consolidated statements of operations.

Deferred contract costs are periodically analyzed for impairment. As of January 31, 2023 and 2022, we have not identified any potential indicators of impairment.
Cost of Revenue
Cost of Revenue

Cost of revenue consists of expenses related to providing platform access to customers and onboarding services. These costs include payments to third-party cloud infrastructure providers for hosting software solutions and costs associated with application service providers utilized to deliver the platform, allocated personnel-related costs, including salaries, cash-based performance compensation, benefits and stock-based compensation, overhead cost allocations related to facilities and shared IT-related expenses, including depreciation expense and amortization of internal use software.
Operating Expenses
Operating Expenses

Operating expenses consist of sales and marketing, research and development, and general and administrative expenses. Personnel costs are the most significant component of operating expenses and consist of salaries, cash performance-based compensation, employee benefits and stock-based compensation. Operating expenses also include overhead cost allocations.
Sales, Marketing, General and Administrative
Sales and Marketing

Sales and marketing expenses consist primarily of personnel costs for sales and marketing organization, costs related to sponsorships, events and advertising, agency costs, travel-related expenses, and allocated overhead costs. Costs associated with our advertising and sales promotions are expensed as incurred. During the fiscal years ended January 31, 2023, 2022, and 2021, we recognized $20.8 million, $12.2 million, and $8.1 million, respectively, in advertising costs, which included brand and sponsorship costs.
General and Administrative

General and administrative expenses consist primarily of personnel costs for finance, legal, human resources and other administrative functions, as well as outside professional services. In addition, general and administrative expense includes non-personnel costs, such as legal, accounting and other professional fees, software costs, certain tax, license and insurance-related expenses and allocated overhead costs.
Research and Development
Research and Development

Research and development expenses consist primarily of personnel costs for engineering, service, design, and information technology teams. Additionally, research and development expenses include allocated overhead costs and contractor fees. Research and development costs are expensed as incurred. Capitalized internal-use software development costs are excluded from research and development expenses as they are capitalized as a component of property and equipment, net and amortized to cost of revenue over the software’s expected useful life, which is generally three years.
Stock-Based Compensation Stock-Based Compensation
We measure and record the expense related to stock-based payment awards based on the fair value of those awards as determined on the date of grant. We recognize stock-based compensation expense over the requisite service period of the individual grant, generally equal to the vesting period, and use the straight-line method to recognize stock-based compensation. We use the Black-Scholes-Merton (“Black-Scholes”) option pricing model to determine the fair value of stock based awards.

We estimate expected forfeitures of stock-based awards at the grant date and recognize compensation cost only for those awards expected to vest. We estimate our forfeitures rate based on an analysis of our actual historical forfeitures materializing in the previous fiscal years, and revise the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. We routinely evaluate the appropriateness of the forfeiture rate based on actual forfeiture experience, analysis of employee turnover and expectations of future option exercise behavior.

We calculate the fair value of options granted by using the Black-Scholes option-pricing model with the following assumptions:

Expected Volatility

We estimate volatility for option grants by evaluating the average historical volatility of a peer group of companies for the period immediately preceding the option grant for a term that is approximately equal to the options’ expected term since we do not have sufficient trading history of our common stock.

Expected Term

The expected term of our stock options represents the period that the stock-based awards are expected to be outstanding. We have elected to use the simplified method to compute the expected term, which we believe is representative of future behavior. Our stock plans provide a contractual term of ten years before the option is forfeited.

Risk-Free Interest Rate

The risk-free interest rate is based on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent term of the expected life of the option on the grant date.

Dividend Yield

We have not declared or paid dividends to date and do not anticipate declaring dividends in the foreseeable future. As such, the dividend yield has been estimated to be zero.

Fair Value of Common Stock

Prior to our IPO, the fair value of the common stock underlying the stock option awards was determined by the board of directors (“the Board”). Given the absence of a public trading market, the Board considered numerous objective and subjective factors to determine the fair value of our common stock at each meeting at which awards were approved. These factors included, but were not limited to, (i) contemporaneous third party valuations of our common stock; (ii) the rights, preferences, and privileges of our convertible preferred stock relative to our common stock; (iii) the lack of marketability of our common stock; (iv) stage and development of our business; (v) general economic conditions; and (vi) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. To evaluate the fair value of the underlying shares for grants between two independent valuations and after the last independent valuation, a linear interpolation framework was used to evaluate.
Subsequent to our IPO, the fair value of each share of underlying common stock is based on the closing price of our Class A common stock as reported on the Nasdaq Stock Market on the date of grant.
Investment Income
Investment Income

Investment income consists primarily of income earned on our investments, cash and cash equivalents and restricted cash.
Other Income (Expense), Net
Other Income (Expense), Net

Other income (expense), net, is primarily comprised of realized and unrealized foreign currency gains and losses.
Leases Leases
We determine if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether we have the right to control the identified asset. Right-of-use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the lease term. ROU assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable.

As the implicit rate in our leases is generally unknown, we use the incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The lease terms may include options to extend or terminate the lease when it is reasonably certain we will exercise any such options. Lease costs for our operating leases are recognized on a straight-line basis over the lease term. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease term. The interest component of finance leases is included in interest expense and recognized using the effective interest method over the lease term. We did not have any finance leases in the periods presented.

We have elected to not separate lease and non-lease components for any leases within our existing classes of assets and, as a result, we account for any lease and non-lease components as a single lease component. We have also elected to not apply the recognition requirement to any leases within our existing classes of assets with a term of 12 months or less (short-term leases). Variable lease costs are comprised primarily of our proportionate share of operating expenses, property taxes, and insurance and is classified as lease cost due to our election to not separate lease and non-lease components.

Operating leases are included in operating lease right-of-use assets, current operating lease liabilities, and non-current in our consolidated balance sheets. Refer to Note 14. Leases, for further information.
Income Taxes
Income Taxes

We account for income taxes using the asset and liability method. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.

In evaluating our ability to recover our deferred income tax assets, we consider all available positive and negative evidence, using a more likely than not standard. The evaluation considers our recent historical operating results, ongoing tax planning, and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. In the event we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance that would reduce the provision for income taxes. Conversely, in the event that all or part of the net deferred tax assets are determined not to be realizable in the future, we would charge an adjustment to the valuation allowance to earnings in the period when such determination is made. As of January 31, 2023, we recorded a full valuation allowance in jurisdictions where we had net deferred tax assets, which consist of net operating loss carryforwards and other basis differences, as we have concluded that it is more likely than not that our deferred tax assets will not be realized.

We recognize tax expense associated with Global Intangible Low-Taxed Income as it is incurred as part of the current income taxes to be paid or refunded for the current period.
We recognize the tax benefits on any uncertain tax positions taken or expected to be taken in the consolidated financial statements when it is more likely than not the position will be realized upon ultimate settlement with tax authorities, assuming full knowledge of the position and relevant facts. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
Recently Adopted and Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncements

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), (“ASC 842”) and issued certain transitional guidance and subsequent amendments between January 2018 and February 2020 within ASU No. 2017-13, ASU No. 2018-01, ASU No. 2018-10, ASU No. 2018-11, ASU No. 2018-20, ASU No. 2019-01, ASU No. 2019-10, ASU No. 2020-02, and ASU No. 2020-05 (collectively, “Topic 842”). The guidance in Topic 842 supersedes the leasing guidance in Topic 840, Leases. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheet for all leases with terms longer than twelve months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the consolidated statements of operations. Per ASU No. 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842): Effective Dates for Certain Entities, issued June 2020, Topic 842, as amended, is effective for fiscal years beginning after
December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Topic 842 is effective for our fiscal year ending January 31, 2022 and interim periods beginning February 1, 2023 with early adoption permitted. While we previously elected to take advantage of the extended transition period available to emerging growth companies for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended, we decided to early adopt Topic 842. We adopted this standard under the modified-retrospective approach, using the practical expedients allowing us to not reassess (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification for any expired leases, and (iii) indirect costs for any existing leases. Additionally, any lease arrangements with a term of 12 months or less will be recognized on the consolidated statements of operations on a straight-line basis over the lease term and any non-lease components shall not be separated from the lease components, but instead accounted for as a single lease component. Upon adoption of ASC 842, we recognized a right-of-use asset of $59.6 million and a lease liability of $61.3 million at February 1, 2022 on our consolidated balance sheets. Prior period amounts were not restated and are reported in accordance with ASC 840. Refer to Note 14. Leases, for further information.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement on Credit Losses on Financial Instruments, and issued subsequent amendments to the initial guidance and transitional guidance between November 2018 and February 2020 within ASU No. 2018-19, ASU No. 2019-04, ASU No. 2019-05, ASU No. 2019-10, ASU No. 2019-11 and ASU No. 2020-02 (collectively, “Topic 326”). Topic 326 introduces new guidance for credit losses on instruments within its scope. The new guidance introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade and other receivables, held-to-maturity debt securities, loans and net investments in leases. The new guidance also modifies the impairment model for available-for-sale debt securities and requires entities to determine whether all or a portion of the unrealized loss on an available-for-sale debt security is a credit loss. Further, the new guidance indicates that entities may not use the length of time a security has been in an unrealized loss position as a factor in concluding whether a credit loss exists. Per ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842), Topic 326, as amended, is effective for (1) public business entities that meet the definition of an SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and (2) all other entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Topic 326 is effective for our fiscal year beginning February 1, 2023 and early adoption is permitted. While we previously elected to take advantage of the extended transition period available to emerging growth companies for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended, we decided to early adopt Topic 326. We determined that the adoption of this ASU did not have a material impact on our consolidated financial statements. As such, we adopted this ASU prospectively on February 1, 2022.

In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes (Topic 740) (“Topic 740”), which removes certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. For public companies, the guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. We adopted ASU 2019-12 on February 1, 2022 and determined that the adoption of this ASU had no material impact on our consolidated financial statements.
In October 2020, FASB issued ASU No. 2020-10, Codification Improvements (“ASU 2020-10”). The amendments in this guidance affect a wide variety of topics in the ASC by either clarifying the codification or correcting unintended application of guidance. The changes are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. For public companies, the guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. We adopted ASU 2020-10 prospectively on February 1, 2022 and determined that this ASU does not have a material impact on our consolidated financial statements.
v3.23.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jan. 31, 2023
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of the cash, cash equivalents, and restricted cash as of January 31, 2023 and 2022 (in thousands):
January 31,
20232022
Cash and cash equivalents$68,587 $478,937 
Restricted cash, noncurrent4,036 4,036 
Total cash, cash equivalents, and restricted cash$72,623 $482,973 
Property and equipment, net The estimated useful lives for significant property and equipment categories are as follows:
Computer equipment, office equipment, and software
3 years
Furniture and fixtures
7 years
Leasehold improvementsShorter of lease term or estimated useful life of assets
Property and equipment, net, consist of the following (in thousands):
January 31,
20232022
Capitalized internal-use software$7,344 $5,353 
Computer equipment, office equipment, and software8,111 3,833 
Leasehold improvements9,410 2,470 
Furniture and fixtures4,085 966 
Total property and equipment28,950 12,622 
Less: accumulated depreciation and amortization(8,611)(5,229)
Total property and equipment, net$20,339 $7,393 
v3.23.1
Revenue from Contracts with Customers (Tables)
12 Months Ended
Jan. 31, 2023
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table presents total revenue by type (in thousands):

Fiscal Year Ended January 31,
202320222021
Subscription$338,351 $221,664 $141,068 
Professional services and other17,075 16,371 9,123 
Total$355,426 $238,035 $150,191 
Total Revenue by Geography
The following table presents total revenue by geography (in thousands):

Fiscal Year Ended January 31,
202320222021
United States$204,931 $142,640 $90,523 
International150,495 95,395 59,668 
Total$355,426 $238,035 $150,191 
Accounts Receivable, Allowance for Credit Loss
The following table presents a reconciliation of the allowance for credit losses on accounts receivable (in thousands):

Allowance for Credit Losses
Balance at January 31, 2022
$743 
Reserve:
Credit losses808 
Deferred revenue1,667 
Write-offs(1,746)
Recoveries141 
Balance at January 31, 2023
$1,613 
Remaining Performance Obligations
The following table presents remaining performance obligations as of the dates indicated below (in millions):

TotalLess than 1 Year1-5 Years
January 31, 2022$373.6 $237.8 $135.8 
April 30, 2022390.9 255.1 135.8 
July 31, 2022410.5 274.2 136.3 
October 31, 2022408.7 283.3 125.4 
January 31, 2023455.7 312.6 143.1 
v3.23.1
Variable Interest Entity and Redeemable Non-Controlling Interest (Tables)
12 Months Ended
Jan. 31, 2023
Noncontrolling Interest [Abstract]  
Redeemable Noncontrolling Interest
The following table summarizes the activity in the redeemable non-controlling interests for the periods indicated below (in thousands):

Balance as of January 31, 2021
$2,233
Investment in redeemable non-controlling interest2,450
Net loss attributable to redeemable non-controlling interest(1,448)
Balance as of January 31, 2022
$3,235
Net loss attributable to redeemable non-controlling interest(1,780)
Balance as of January 31, 2023
$1,455
Schedule of Variable Interest Entity Assets and Liabilities
The total combined VIE assets, which represent the maximum exposure to loss, and liabilities were as follows (in thousands):
January 31,
20232022
Assets:
Cash and cash equivalents$4,849 $6,705 
Accounts receivable, net of allowance535 143 
Prepaid expenses and other current assets331 196 
Total current assets5,715 7,044 
Property and equipment, net84 38 
Deferred contract costs902 609 
Other assets29 32 
Total assets$6,730 $7,723 
Liabilities:
Accounts payable$67 $106 
Accrued expenses and other current liabilities2,793 829 
Deferred revenue1,918 725 
Total liabilities4,778 1,660 
Other long-term liabilities322 — 
Total liabilities$5,100 $1,660 
v3.23.1
Prepaid Expenses and Other Current Assets (Tables)
12 Months Ended
Jan. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consist of the following (in thousands):
January 31,
20232022
Prepaid software subscriptions$12,574 $19,396 
Prepaid advertising1,322 704 
Prepaid insurance2,795 4,372 
Investment interest receivable2,013 259 
Consumption tax receivable1,045 667 
Prepaid employee bonuses538 332 
Prepaid employee benefits811 233 
Other5,065 3,625 
Total prepaid expenses and other current assets$26,163 $29,588 
v3.23.1
Fair Value Measurements (Tables)
12 Months Ended
Jan. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table sets forth our financial instruments that were measured at fair value on a recurring basis at the periods indicated below, by level within the fair value hierarchy (in thousands):
January 31, 2023
Level 1Level 2Level 3Total
Cash equivalents
Money market funds$30,873 $— $— $30,873 
30,873 — — 30,873 
Marketable securities
U.S. government securities$307,744 $— $— $307,744 
Foreign bonds— 2,967 — 2,967 
Corporate debt securities— 99,372 — 99,372 
Total marketable securities307,744 102,339 — 410,083 
Total$338,617 $102,339 $— $440,956 
January 31, 2022
Level 1Level 2Level 3Total
Cash equivalents
Money market funds$439,627 $— $— $439,627 
439,627 — — 439,627 
Marketable securities
U.S. government bonds$4,006 $— $— $4,006 
Foreign bonds— 3,203 — 3,203 
Commercial paper— 18,993 — 18,993 
Corporate debt securities— 3,020 — 3,020 
Asset-backed securities— 5,934 — 5,934 
Total marketable securities4,006 31,150 — 35,156 
Total$443,633 $31,150 $— $474,783 
v3.23.1
Marketable Securities (Tables)
12 Months Ended
Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Components of Marketable Securities
Marketable securities consist of the following for the periods presented (in thousands):

January 31, 2023
Cost or Amortized CostGross Unrealized GainsGross Unrealized LossesTotal Estimated Fair Value
U.S. government securities$312,044 $31 $(4,331)$307,744 
Foreign bonds3,028 — (61)2,967 
Corporate debt securities100,589 27 (1,244)99,372 
Total$415,661 $58 $(5,636)$410,083 

January 31, 2022
Cost or Amortized CostGross Unrealized GainsGross Unrealized LossesTotal Estimated Fair Value
U.S. government bonds$4,021 $— $(15)$4,006 
Foreign bonds3,203 — — 3,203 
Commercial paper18,993 — — 18,993 
Corporate debt securities3,025 — (5)3,020 
Asset-backed securities5,941 — (7)5,934 
Total$35,183 $— $(27)$35,156 
Marketable Securities by Contractual Maturity
The contractual maturities of the investments classified as available-for-sale marketable securities are as follows (in thousands):

January 31, 2023
Amortized CostEstimated Fair Value
Due within 1 year$247,214 $244,280 
Due in 1 year through 5 years168,447 165,803 
Total$415,661 $410,083 

January 31, 2022
Amortized CostEstimated Fair Value
Due within 1 year$33,671 $33,646 
Due in 1 year through 5 years1,512 1,510 
Total$35,183 $35,156 
Investment Income
Fiscal Year Ended January 31,
202320222021
Interest income$7,393 $506 $1,185 
Amortization of discount/premium, net1,336 (369)(345)
Investment income$8,729 $137 $840 
v3.23.1
Property and Equipment, Net (Tables)
12 Months Ended
Jan. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and equipment, net The estimated useful lives for significant property and equipment categories are as follows:
Computer equipment, office equipment, and software
3 years
Furniture and fixtures
7 years
Leasehold improvementsShorter of lease term or estimated useful life of assets
Property and equipment, net, consist of the following (in thousands):
January 31,
20232022
Capitalized internal-use software$7,344 $5,353 
Computer equipment, office equipment, and software8,111 3,833 
Leasehold improvements9,410 2,470 
Furniture and fixtures4,085 966 
Total property and equipment28,950 12,622 
Less: accumulated depreciation and amortization(8,611)(5,229)
Total property and equipment, net$20,339 $7,393 
v3.23.1
Accrued Expenses and Other Current Liabilites (Tables)
12 Months Ended
Jan. 31, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consists of the following (in thousands):
January 31,
20232022
Accrued compensation costs$12,644 $14,075 
Accrued software subscriptions8,454 3,217 
Accrued commissions6,205 5,961 
Accrued professional service fees1,779 2,218 
Accrued advertising922 660 
Accrued tax liability2,152 1,951 
Other5,259 3,541 
Total accrued expenses and other current liabilities$37,415 $31,623 
v3.23.1
Employee Stock Plans (Tables)
12 Months Ended
Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
A summary of stock option activity for the periods presented, is as follows:
Options Outstanding
Number of OptionsWeighted Average Exercise PriceAverage Remaining Contractual Life (Years)Aggregate Intrinsic Value
(in thousands)
Balance as of January 31, 2021
11,186,400$3.587.99$351,321
Granted3,120,51635.02
Exercised(2,855,522)2.94
Forfeited(415,690)5.48
Balance as of January 31, 2022
11,035,704$12.567.69$413,384
Grantedn/a
Exercised(2,155,929)3.94
Forfeited(707,834)19.13
Balance as of January 31, 2023
8,171,941$14.276.58$153,237
Vested and expected to vest as of January 31, 2023
7,861,331$13.666.52$151,740
Exercisable - January 31, 2023
4,916,568$6.835.72$125,404
Fiscal Year Ended January 31,
202320222021
Weighted-average grant date fair value per share of options granted during each respective periodn/a$24.53$7.41
Aggregate intrinsic value of options exercised during each respective period (in thousands)$71.16$121.90$78.90
Schedule of Stock Option Valuation Assumptions
We estimate the fair value of stock options using the Black-Scholes option-pricing model on the date of grant. The assumptions used in the Black-Scholes option-pricing model were as follows:

Fiscal Year Ended January 31,
202320222021
Dividend yield (in percentage)n/a—%—%
Expected volatility (in percentage)n/a
61.8 - 66.1%
55.7 - 62.5%
Expected term (in years)n/a
5.9 - 6.7
5.5 - 6.1
Risk-free interest rate (in percentage)n/a
1.0 - 1.2%
0.3 - 1.5%
Fair value of common stockn/a
$65.00
$5.28 - $28.35
Schedule of Summarized Unvested RSU Award Activity
The following table summarizes unvested RSU award activity and related information:

SharesWeighted-Average Grant Date Fair Value
Balance as of January 31, 2022
1,355,065
Granted4,430,554$37.11
Vested(630,851)$48.51
Forfeited(529,250)$45.29
Balance as of January 31, 2023
4,625,518
Schedule of Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense, which was included in the consolidated statements of operations as follows (in thousands):

Fiscal Year Ended January 31,
202320222021
Cost of revenue$3,616 $2,185 $650 
Sales and marketing23,871 16,281 2,892 
Research and development28,897 15,613 2,102 
General and administrative15,833 13,101 1,896 
Stock-based compensation, net of amounts capitalized$72,217 $47,180 $7,540 
Capitalized stock-based compensation expense1,121 387 126 
Total stock-based compensation expense$73,338 $47,567 $7,666 
Schedule of Employee Service Share Based Compensation Unrecognized Compensation Costs
As of January 31, 2023, total compensation cost not yet recognized related to unvested equity awards and the weighted-average remaining period over which these costs are expected to be realized were as follows:

Stock OptionsRSUs
Unrecognized compensation costs (in thousands)$44,170$114,730
Weighted-average remaining recognition period (years)2.472.96
v3.23.1
Leases (Tables)
12 Months Ended
Jan. 31, 2023
Leases [Abstract]  
Schedule of Lease Cost, Terms, Discount Rate and Other Information
The following table presents information on our operating leases for the fiscal year ended January 31, 2023 (in thousands):

Fiscal Year Ended January 31, 2023
Operating lease cost$13,638 
Variable lease cost2,521 
Short-term lease cost1,795 
Total net lease cost$17,954
The Company's lease terms and discount rates are as follows:
January 31, 2023
Weighted-average remaining lease term (years)6.6
Weighted-average discount rate5.5 %

Other information for the Company's leases is as follows (in thousands):
Fiscal Year Ended January 31, 2023
Cash paid for amounts included in the measurement of lease liabilities$10,292 
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities$— 
Schedule of Maturities of Operations Lease Liabilities
The future maturities of the Company’s operating lease liabilities by fiscal year were as follows (in thousands):

2024$10,705 
202510,621 
20268,318 
20277,351 
20285,932 
Thereafter18,755 
Total future undiscounted lease payments61,682 
Less: imputed interest(10,397)
Less: tenant improvement allowance not yet received— 
Total reported lease liability$51,285 
v3.23.1
Income Taxes (Tables)
12 Months Ended
Jan. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The components of the provision for (benefit from) income taxes are as follows (in thousands):

Fiscal Year Ended January 31,
202320222021
Current:
Federal$— $— $— 
State and local52 15 26 
Foreign496 (100)451 
Total current548 (85)477 
Deferred:
Federal— — — 
State and local— — — 
Foreign35 (80)60 
Total deferred35 (80)60 
Provision for (benefit from) income taxes$583 $(165)$537 
Schedule of Income before Income Tax, Domestic and Foreign
The components of loss before income taxes are as follows (in thousands):

Fiscal Year Ended January 31,
202320222021
United States$(138,226)$(76,030)$(33,352)
Foreign(1,937)(2,302)1,920 
Loss before provision for income taxes$(140,163)$(78,332)$(31,432)
Schedule of Effective Income Tax Rate Reconciliation A reconciliation of the benefit from (provision for) income taxes to the amounts computed by applying the statutory federal income tax rate to earnings before income taxes is shown as follows:
Fiscal Year Ended January 31,
202320222021
Statutory income tax expense21.0 %21.0 %21.0 %
Foreign tax rate differential0.1 %0.8 %0.2 %
State taxes— %— %(0.1)%
Permanent items(0.3)%(3.0)%(2.0)%
Change in valuation allowance(24.2)%(26.5)%(21.6)%
Stock-based compensation1.5 %5.8 %(1.4)%
Tax credits1.5 %2.1 %2.2 %
Effective tax rate(0.4)%0.2 %(1.7)%
Schedule of Deferred Tax Assets and Liabilities
The tax effects of cumulative temporary differences that give rise to significant deferred tax assets and deferred tax liabilities are presented below (in thousands). The valuation allowance relates to deferred tax assets for which it is more likely than not that the tax benefit will not be realized.
Fiscal Year Ended January 31,
20232022
Deferred tax assets:
Loss carryforwards$72,878 $46,886 
Compensation and benefits16,834 10,772 
Operating lease liabilities12,679 — 
Tax credits5,689 3,541 
Capitalized costs5,568 — 
Other3,999 1,429 
Deferred tax assets117,647 62,628 
Less: valuation allowance(93,150)(52,209)
Deferred tax asset, net of valuation allowance24,497 10,419 
Deferred tax liabilities:
Deferred contract costs(11,826)(10,286)
Property, equipment and software(1,264)(133)
Operating lease right-of-use assets(11,447)— 
Deferred tax liabilities(24,537)(10,419)
Net deferred tax assets/(liabilities)$(40)$— 
Schedule of Unrecognized Tax Benefits Roll Forward
A reconciliation of the beginning and ending amount of unrecognized tax benefits, including penalties but excluding interest, is as follows (in thousands):

Fiscal Year Ended January 31,
202320222021
Balance at February 1$647 $902 $647 
Additions for tax positions of prior years— — 902 
Reductions for tax positions of prior years(647)(255)(647)
Balance at January 31$— $647 $902 
v3.23.1
Net Loss per Share (Tables)
12 Months Ended
Jan. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Net Loss Per Share
Fiscal Year Ended January 31,
202320222021
Numerator:
Net loss attributable to Braze, Inc.$(138,966)$(76,719)$(31,752)
Denominator:
Weighted-average shares of Braze, Inc. common stock outstanding94,597 35,078 18,205 
Less: weighted-average unvested shares of Braze, Inc. subject to repurchase(28)(181)(233)
Weighted-average shares used to calculate net loss per share attributable to Braze, Inc. common stockholders, basic and diluted94,569 34,897 17,972 
Net loss per share attributable to Braze, Inc. common stockholders, basic and diluted$(1.47)$(2.20)$(1.77)
Schedule of Potentially Diluted Securities
The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per share attributable to Braze, Inc. common stockholders for the periods presented, because their inclusion would be anti-dilutive (in thousands):
Fiscal Year Ended January 31,
202320222021
Convertible preferred stock on an as-converted basis— — 62,831 
Options to purchase common stock8,172 11,036 11,186 
Restricted stock units4,626 1,355 — 
ESPP shares estimated to be purchased121 — — 
Warrants to purchase common stock— — 218 
Total12,919 12,391 74,235 
v3.23.1
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Feb. 01, 2022
Jan. 31, 2020
Disaggregation of Revenue [Line Items]          
Restricted cash $ 4,000 $ 4,000      
Stockholders' equity $ 445,303 501,583 $ (108,507)   $ (86,876)
Amortization period, contract cost 4 years        
Asset impairment charges $ 0 0      
Advertising costs 20,800 12,200 $ 8,100    
Operating lease right-of-use assets 46,261 $ 0      
Total reported lease liability $ 51,285        
Software          
Disaggregation of Revenue [Line Items]          
Estimated useful life 3 years        
Options to purchase common stock          
Disaggregation of Revenue [Line Items]          
Expected term (in years) 10 years        
Minimum          
Disaggregation of Revenue [Line Items]          
Contract term 1 year        
Expected term (in years)   5 years 10 months 24 days 5 years 6 months    
Minimum | Renewal          
Disaggregation of Revenue [Line Items]          
Amortization period, contract cost 1 year        
Maximum          
Disaggregation of Revenue [Line Items]          
Contract term 5 years        
Expected term (in years)   6 years 8 months 12 days 6 years 1 month 6 days    
Maximum | Renewal          
Disaggregation of Revenue [Line Items]          
Amortization period, contract cost 3 years        
Accumulated Deficit          
Disaggregation of Revenue [Line Items]          
Stockholders' equity $ (353,927) $ (214,961) $ (138,242)   $ (106,490)
Cumulative Effect, Period of Adoption, Adjustment | Minimum | Pro Forma          
Disaggregation of Revenue [Line Items]          
Operating lease right-of-use assets       $ 59,600  
Total reported lease liability       59,600  
Cumulative Effect, Period of Adoption, Adjustment | Maximum | Pro Forma          
Disaggregation of Revenue [Line Items]          
Operating lease right-of-use assets       61,300  
Total reported lease liability       $ 61,300  
v3.23.1
Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2020
Accounting Policies [Abstract]        
Cash and cash equivalents $ 68,587 $ 478,937    
Restricted cash, noncurrent 4,036 4,036    
Total cash, cash equivalents, and restricted cash $ 72,623 $ 482,973 $ 33,018 $ 11,602
v3.23.1
Summary Of Significant Accounting Policies - Estimated Useful Lives of Significant Property and Equipment Categories (Details)
12 Months Ended
Jan. 31, 2023
Computer equipment, office equipment, and software  
Property, Plant and Equipment [Line Items]  
Estimated useful life 3 years
Furniture and fixtures  
Property, Plant and Equipment [Line Items]  
Estimated useful life 7 years
v3.23.1
Revenue from Contracts with Customers - Disaggregation of Revenue by Type (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Disaggregation of Revenue [Line Items]      
Revenue $ 355,426 $ 238,035 $ 150,191
Subscription      
Disaggregation of Revenue [Line Items]      
Revenue 338,351 221,664 141,068
Professional Services and Other      
Disaggregation of Revenue [Line Items]      
Revenue $ 17,075 $ 16,371 $ 9,123
v3.23.1
Revenue from Contracts with Customers - Disaggregation of Revenue by Geography (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Disaggregation of Revenue [Line Items]      
Revenue $ 355,426 $ 238,035 $ 150,191
United States      
Disaggregation of Revenue [Line Items]      
Revenue 204,931 142,640 90,523
Foreign      
Disaggregation of Revenue [Line Items]      
Revenue $ 150,495 $ 95,395 $ 59,668
v3.23.1
Revenue from Contracts with Customers - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Revenue from Contract with Customer [Abstract]      
Unbilled contracts receivable $ 1.0 $ 2.2  
Contract asset 0.8 0.8  
Revenue recognized from previously recorded contract liabilities $ 126.1 $ 74.6 $ 51.2
v3.23.1
Revenue from Contracts with Customers - Accounts Receivable, Allowance for Credit Loss (Details)
$ in Thousands
12 Months Ended
Jan. 31, 2023
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Beginning balance $ 743
Credit losses 808
Deferred revenue 1,667
Write-offs (1,746)
Recoveries 141
Ending balance $ 1,613
v3.23.1
Revenue from Contracts with Customers - Remaining Performance Obligations (Details) - USD ($)
$ in Millions
Jan. 31, 2023
Oct. 31, 2022
Jul. 31, 2022
Apr. 30, 2022
Jan. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount $ 455.7 $ 408.7 $ 410.5 $ 390.9 $ 373.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-02-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount         $ 237.8
Revenue, remaining performance obligation, period         1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-05-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount       $ 255.1  
Revenue, remaining performance obligation, period       1 year  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-08-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount     $ 274.2    
Revenue, remaining performance obligation, period     1 year    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-11-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount   $ 283.3      
Revenue, remaining performance obligation, period   1 year      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount $ 312.6       $ 135.8
Revenue, remaining performance obligation, period 1 year       4 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-05-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount       $ 135.8  
Revenue, remaining performance obligation, period       4 years  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-08-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount     $ 136.3    
Revenue, remaining performance obligation, period     4 years    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount   $ 125.4      
Revenue, remaining performance obligation, period   4 years      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]          
Revenue, remaining performance obligation, amount $ 143.1        
Revenue, remaining performance obligation, period 4 years        
v3.23.1
Variable Interest Entity and Redeemable Non-Controlling Interest - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 13 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Jan. 31, 2023
Noncontrolling Interest [Line Items]        
Deferred compensation liability, classified, noncurrent       $ 0.3
Braze KK        
Noncontrolling Interest [Line Items]        
Consideration received $ 5.0 $ 5.0 $ 10.0  
v3.23.1
Variable Interest Entity and Redeemable Non-Controlling Interest - Redeemable Noncontrolling Interest (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Noncontrolling Interest [Roll Forward]      
Beginning balance $ 3,235 $ 2,233 $ 0
Investment in redeemable non-controlling interests   2,450 2,450
Net loss attributable to redeemable non-controlling interest (1,780) (1,448) (217)
Ending balance $ 1,455 $ 3,235 $ 2,233
v3.23.1
Variable Interest Entity and Redeemable Non-Controlling Interest - Variable Interest Entity Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Assets [Abstract]    
Cash and cash equivalents $ 68,587 $ 478,937
Accounts receivable, net of allowance of $1,613 and $743 at January 31, 2023 and January 31, 2022, respectively 78,338 64,504
Prepaid expenses and other current assets 26,163 29,588
Total current assets 583,171 608,185
Property and equipment, net 20,339 7,393
Deferred contract costs 48,451 41,689
Other assets 3,148 4,959
TOTAL ASSETS 705,406 666,262
Liabilities [Abstract]    
Accounts payable 3,101 2,083
Accrued expenses and other current liabilities 37,415 31,623
Deferred revenue 166,092 126,260
Total current liabilities 217,303 159,966
Other long-term liabilities 755 1,478
TOTAL LIABILITIES 258,648 161,444
Variable Interest Entity, Primary Beneficiary | Braze KK    
Assets [Abstract]    
Cash and cash equivalents 4,849 6,705
Accounts receivable, net of allowance of $1,613 and $743 at January 31, 2023 and January 31, 2022, respectively 535 143
Prepaid expenses and other current assets 331 196
Total current assets 5,715 7,044
Property and equipment, net 84 38
Deferred contract costs 902 609
Other assets 29 32
TOTAL ASSETS 6,730 7,723
Liabilities [Abstract]    
Accounts payable 67 106
Accrued expenses and other current liabilities 2,793 829
Deferred revenue 1,918 725
Total current liabilities 4,778 1,660
Other long-term liabilities 322 0
TOTAL LIABILITIES $ 5,100 $ 1,660
v3.23.1
Prepaid Expenses and Other Current Assets - Summary (Details) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid software subscriptions $ 12,574 $ 19,396
Prepaid advertising 1,322 704
Prepaid insurance 2,795 4,372
Investment interest receivable 2,013 259
Consumption tax receivable 1,045 667
Prepaid employee bonuses 538 332
Prepaid employee benefits 811 233
Other 5,065 3,625
Total prepaid expenses and other current assets $ 26,163 $ 29,588
v3.23.1
Fair Value Measurements - Fair Value of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents $ 30,873 $ 439,627
Marketable securities 410,083 35,156
Total 440,956 474,783
U.S. government bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 307,744 4,006
Foreign bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 2,967 3,203
Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities   18,993
Corporate debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 99,372 3,020
Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities   5,934
Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 30,873 439,627
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 30,873 439,627
Marketable securities 307,744 4,006
Total 338,617 443,633
Level 1 | U.S. government bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 307,744 4,006
Level 1 | Foreign bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Level 1 | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities   0
Level 1 | Corporate debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Level 1 | Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities   0
Level 1 | Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 30,873 439,627
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 0 0
Marketable securities 102,339 31,150
Total 102,339 31,150
Level 2 | U.S. government bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Level 2 | Foreign bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 2,967 3,203
Level 2 | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities   18,993
Level 2 | Corporate debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 99,372 3,020
Level 2 | Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities   5,934
Level 2 | Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 0 0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 0 0
Marketable securities 0 0
Total 0 0
Level 3 | U.S. government bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Level 3 | Foreign bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Level 3 | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities   0
Level 3 | Corporate debt securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 0 0
Level 3 | Asset-backed securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities   0
Level 3 | Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents $ 0 $ 0
v3.23.1
Marketable Securities - Components of Marketable Securities (Details) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Debt Securities, Available-for-sale [Line Items]    
Total $ 415,661 $ 35,183
Gross Unrealized Gains 58 0
Gross Unrealized Losses (5,636) (27)
Total Estimated Fair Value 410,083 35,156
U.S. government bonds    
Debt Securities, Available-for-sale [Line Items]    
Total 312,044 4,021
Gross Unrealized Gains 31 0
Gross Unrealized Losses (4,331) (15)
Total Estimated Fair Value 307,744 4,006
Foreign bonds    
Debt Securities, Available-for-sale [Line Items]    
Total 3,028 3,203
Gross Unrealized Gains 0 0
Gross Unrealized Losses (61) 0
Total Estimated Fair Value 2,967 3,203
Commercial paper    
Debt Securities, Available-for-sale [Line Items]    
Total   18,993
Gross Unrealized Gains   0
Gross Unrealized Losses   0
Total Estimated Fair Value   18,993
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Total 100,589 3,025
Gross Unrealized Gains 27 0
Gross Unrealized Losses (1,244) (5)
Total Estimated Fair Value $ 99,372 3,020
Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Total   5,941
Gross Unrealized Gains   0
Gross Unrealized Losses   (7)
Total Estimated Fair Value   $ 5,934
v3.23.1
Marketable Securities - Narrative (Details)
Jan. 31, 2023
USD ($)
security
Jan. 31, 2022
USD ($)
Investments, Debt and Equity Securities [Abstract]    
Debt securities, available for sale, accrued interest $ 2,000,000 $ 300,000
Number of available for sale debt securities in unrealized loss position for greater than 12 months (in securities) | security 0  
Debt securities, available-for-sale, allowance for credit loss, excluding accrued interest $ 0  
Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Prepaid expenses and other current assets  
v3.23.1
Marketable Securities - Contractual Maturity (Details) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Amortized Cost    
Due within 1 year $ 247,214 $ 33,671
Due in 1 year through 5 years 168,447 1,512
Total 415,661 35,183
Estimated Fair Value    
Due within 1 year 244,280 33,646
Due in 1 year through 5 years 165,803 1,510
Total $ 410,083 $ 35,156
v3.23.1
Marketable Securities - Investment Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Investments, Debt and Equity Securities [Abstract]      
Interest income $ 7,393 $ 506 $ 1,185
Amortization of discount/premium, net 1,336 (369) (345)
Investment income $ 8,729 $ 137 $ 840
v3.23.1
Property and Equipment, Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 28,950 $ 12,622  
Less: accumulated depreciation and amortization (8,611) (5,229)  
Total property and equipment, net 20,339 7,393  
Depreciation 3,400 2,800 $ 1,600
Transfers and changes 1,200    
Capitalized internal-use software 2,000 2,400 2,100
Cost of revenue      
Property, Plant and Equipment [Line Items]      
Amortization for capital internal-use software 1,700 1,200 $ 500
Capitalized internal-use software      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 7,344 5,353  
Computer equipment, office equipment, and software      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 8,111 3,833  
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 9,410 2,470  
Furniture and fixtures      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 4,085 $ 966  
v3.23.1
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Payables and Accruals [Abstract]    
Accrued compensation costs $ 12,644 $ 14,075
Accrued software subscriptions 8,454 3,217
Accrued commissions 6,205 5,961
Accrued professional service fees 1,779 2,218
Accrued advertising 922 660
Accrued tax liability 2,152 1,951
Other 5,259 3,541
Total accrued expenses and other current liabilities $ 37,415 $ 31,623
v3.23.1
Employee Benefit Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Retirement Benefits [Abstract]      
Contributions $ 4.7 $ 2.4 $ 1.5
v3.23.1
Stockholders' Equity (Deficit) - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Jan. 31, 2023
vote
class
shares
Jan. 31, 2023
USD ($)
vote
class
shares
Class of Warrant or Right [Line Items]    
Classes of common stock (in classes) | class 2 2
Threshold for conversion 10.00% 10.00%
Charitable donation (in shares) | shares 0  
Charitable donation | $   $ 4.3
Class A common stock    
Class of Warrant or Right [Line Items]    
Votes per share (in votes) 1 1
Common stock, votes per share, converted 1 1
Charitable donation (in shares) | shares   96,465
Class B common stock    
Class of Warrant or Right [Line Items]    
Votes per share (in votes) 10 10
v3.23.1
Employee Stock Plans - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 01, 2022
Nov. 30, 2021
Mar. 31, 2021
Jan. 31, 2023
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation         $ 72,217 $ 47,180 $ 7,540
Common Stock | 2021 Secondary Transaction, Shares Sold By Employees              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Shares sold (in shares)     292,486        
Stock-based compensation expense     $ 3,000        
RSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award cliff vesting period         4 years    
2021 Equity Incentive Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of shares reserved for future issuance (in shares)   25,660,249          
Automatic increase period   10 years          
Increase in shares authorized, percentage of total shares   5.00%          
Additional shares (in shares) 4,648,401            
Employee Stock Purchase Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Automatic increase period   10 years          
Increase in shares authorized, percentage of total shares   1.00%          
Additional shares (in shares) 929,680            
Automatic increase in ESPP (in shares)   2,737,000          
Purchase price as a percentage of market value         85.00%    
Employee Stock Purchase Plan | Employee stock              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of shares reserved for issuance (in shares)   1,825,000          
Stock-based compensation       $ 1,800      
Share-based compensation amount withheld from employees for future purchase       $ 300 $ 300    
Shares issued in period (in shares)         125,276    
Number available for grant (in shares)       2,629,404 2,629,404    
v3.23.1
Employee Stock Plans - Schedule of Stock Option Activity (Details) - USD ($)
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Number of Options      
Beginning balance in shares) 11,035,704 11,186,400  
Granted (in shares) 0 3,120,516  
Exercised (in shares) (2,155,929) (2,855,522)  
Forfeited (in shares) (707,834) (415,690)  
Ending balance (in shares) 8,171,941 11,035,704 11,186,400
Vested and expected to vest (in shares) 7,861,331    
Exercisable, number (in shares) 4,916,568    
Weighted Average Exercise Price      
Beginning balance (in dollars per share) $ 12.56 $ 3.58  
Granted (in dollars per share)   35.02  
Exercised (in dollars per share) 3.94 2.94  
Forfeited (in dollars per share) 19.13 5.48  
Ending balance (in dollars per share) 14.27 $ 12.56 $ 3.58
Vested and expected to vest (in dollars per share) 13.66    
Exercisable (in dollars per share) $ 6.83    
Options, outstanding, weighted average remaining contractual life 6 years 6 months 29 days 7 years 8 months 8 days 7 years 11 months 26 days
Options, vested and expected to vest, weighted average remaining contractual life 6 years 6 months 7 days    
Options, exercisable, weighted average remaining contractual life 5 years 8 months 19 days    
Options, outstanding, intrinsic value $ 153,237,000 $ 413,384,000 $ 351,321,000
Options, vested and expected to vest, intrinsic value 151,740,000    
Options, exercisable, intrinsic value 125,404,000    
Weighted-average grant date fair value of options granted (in dollars per share)   $ 24.53 $ 7.41
Options, exercised in period, intrinsic value $ 71,160,000 $ 121,900 $ 78,900
v3.23.1
Employee Stock Plans - Assumptions in Calculating Stock Option Awards (Details) - $ / shares
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected volatility, minimum   61.80% 55.70%
Expected volatility, maximum   66.10% 62.50%
Risk-free interest rate, minimum   1.00% 0.30%
Risk-free interest rate, maximum   120.00% 1.50%
Options to purchase common stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Dividend yield   0.00% 0.00%
Expected term (in years) 10 years    
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years)   5 years 10 months 24 days 5 years 6 months
Fair value of common stock (in dollars per share)   $ 65.00 $ 5.28
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years)   6 years 8 months 12 days 6 years 1 month 6 days
Fair value of common stock (in dollars per share)     $ 28.35
v3.23.1
Employee Stock Plans - Schedule of Summarized Unvested RSU Award Activity (Details) - RSUs
12 Months Ended
Jan. 31, 2023
$ / shares
shares
Stock units  
Beginning balance, outstanding (in shares) | shares 1,355,065
Granted (in shares) | shares 4,430,554
Vested (in shares) | shares (630,851)
Forfeited (in shares) | shares (529,250)
Ending balance, outstanding (in shares) | shares 4,625,518
Weighted-average grant date fair value  
Beginning balance (in dollars per share) | $ / shares
Granted (in dollars per share) | $ / shares 37.11
Vested (in dollars per share) | $ / shares 48.51
Forfeited (in shares) | $ / shares 45.29
Ending balance (in dollars per share) | $ / shares
v3.23.1
Employee Stock Plans - Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation $ 72,217 $ 47,180 $ 7,540
Capitalized stock-based compensation expense 1,121 387 126
Total stock-based compensation expense 73,338 47,567 7,666
Cost of revenue      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation 3,616 2,185 650
Sales and marketing      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation 23,871 16,281 2,892
Research and development      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation 28,897 15,613 2,102
General and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation $ 15,833 $ 13,101 $ 1,896
v3.23.1
Employee Stock Plans - Compensation Cost by Plan (Details)
$ in Thousands
12 Months Ended
Jan. 31, 2023
USD ($)
Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation costs (in thousands) $ 44,170
Weighted-average remaining recognition period (years) 2 years 5 months 19 days
RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation costs (in thousands) $ 114,730
Weighted-average remaining recognition period (years) 2 years 11 months 15 days
v3.23.1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
Jan. 31, 2023
Jan. 31, 2022
Commitments and Contingencies Disclosure [Abstract]    
Taxes payable $ 0.5 $ 1.3
v3.23.1
Leases - Narrative (Details)
€ in Millions, $ in Millions
1 Months Ended
Nov. 30, 2022
USD ($)
ft²
Oct. 31, 2022
EUR (€)
Jan. 31, 2023
Lessee, Lease, Description [Line Items]      
Area of real estate property | ft² 92,300    
Sublease, lease not yet commenced, rent expense $ 0.6    
Lessee, sublease, lease not yet commenced, rent abatement $ 6.6    
Rental expense for operating leases | €   € 0.1  
Minimum      
Leases [Abstract]      
Term of contract     1 year
Lessee, Lease, Description [Line Items]      
Term of contract     1 year
Maximum      
Leases [Abstract]      
Term of contract     10 years
Lessee, Lease, Description [Line Items]      
Term of contract     10 years
v3.23.1
Leases - Schedule of Lease, Cost (Details)
$ in Thousands
3 Months Ended
Jan. 31, 2023
USD ($)
Leases [Abstract]  
Operating lease cost $ 13,638
Variable lease cost 2,521
Short-term lease cost 1,795
Total net lease cost $ 17,954
v3.23.1
Leases - Maturities of Operating Lease Liabilities (Details)
$ in Thousands
Jan. 31, 2023
USD ($)
Leases [Abstract]  
2024 $ 10,705
2025 10,621
2026 8,318
2027 7,351
2028 5,932
Thereafter 18,755
Total future undiscounted lease payments 61,682
Less: imputed interest (10,397)
Less: tenant improvement allowance not yet received 0
Total reported lease liability $ 51,285
v3.23.1
Leases - Lease Terms and Discount Rates (Details)
Jan. 31, 2023
Leases [Abstract]  
Weighted-average remaining lease term (years) 6 years 7 months 6 days
Weighted-average discount rate 5.50%
v3.23.1
Leases - Other Information for the Company's Leases (Details)
$ in Thousands
12 Months Ended
Jan. 31, 2023
USD ($)
Leases [Abstract]  
Cash paid for amounts included in the measurement of lease liabilities $ 10,292
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities $ 0
v3.23.1
Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Current:      
Federal $ 0 $ 0 $ 0
State and local 52 15 26
Foreign 496 (100) 451
Total current 548 (85) 477
Deferred:      
Federal 0 0 0
State and local 0 0 0
Foreign 35 (80) 60
Deferred Income Tax Expense (Benefit), Total 35 (80) 60
Provision for (benefit from) income taxes $ 583 $ (165) $ 537
v3.23.1
Income Taxes - Income before Income Tax, Domestic and Foreign (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Income Tax Disclosure [Abstract]      
United States $ (138,226) $ (76,030) $ (33,352)
Foreign (1,937) (2,302) 1,920
Loss before provision for income taxes $ (140,163) $ (78,332) $ (31,432)
v3.23.1
Income Taxes - Reconciliation of the Statutory Federal Income Tax Rate to the Effective Tax Rate (Details)
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Income Tax Disclosure [Abstract]      
Statutory income tax expense 21.00% 21.00% 21.00%
Foreign tax rate differential 0.10% 0.80% 0.20%
State taxes 0.00% 0.00% (0.10%)
Permanent items (0.30%) (3.00%) (2.00%)
Change in valuation allowance (24.20%) (26.50%) (21.60%)
Stock-based compensation 1.50% 5.80% (1.40%)
Tax credits 1.50% 2.10% 2.20%
Effective tax rate (0.40%) 0.20% (1.70%)
v3.23.1
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Deferred tax assets:    
Loss carryforwards $ 72,878 $ 46,886
Compensation and benefits 16,834 10,772
Operating lease liabilities 12,679 0
Tax credits 5,689 3,541
Capitalized costs 5,568 0
Other 3,999 1,429
Deferred tax assets 117,647 62,628
Less: valuation allowance (93,150) (52,209)
Deferred tax asset, net of valuation allowance 24,497 10,419
Deferred tax liabilities:    
Deferred contract costs (11,826) (10,286)
Property, equipment and software (1,264) (133)
Operating lease right-of-use assets 11,447 0
Deferred tax liabilities (24,537) (10,419)
Net deferred tax liability $ (40) $ 0
v3.23.1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2020
Operating Loss Carryforwards [Line Items]        
Operating loss carryforward, foreign $ 8,300      
Decrease in operating loss carryforward     $ (13,800)  
Decrease in tax credit carryforward     (700)  
Increase in valuation allowance 40,900 $ 22,900    
Penalties and interest accrued 0 0 0  
Unrecognized tax benefits 0 647 $ 902 $ 647
Research tax credit carryforward        
Operating Loss Carryforwards [Line Items]        
Tax credit carryforward 5,700      
Federal        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards 281,600 179,400    
Operating loss carryforward not subject to expiration 242,200      
Operating loss carryforward subject to expiration 39,400      
State and Local Jurisdiction        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards $ 182,400 $ 119,100    
v3.23.1
Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Unrecognized tax benefits, beginning of year $ 647 $ 902 $ 647
Additions for tax positions of prior years 0 0 902
Reductions for tax positions of prior years (647) (255) (647)
Unrecognized tax benefits, end of year $ 0 $ 647 $ 902
v3.23.1
Net Loss per Share - Schedule of Net Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Numerator:      
Net loss attributable to Braze, Inc. $ (138,966) $ (76,719) $ (31,752)
Denominator:      
Weighted-average shares of Braze, Inc. common stock outstanding, basic (in shares) 94,597 35,078 18,205
Less: weighted-average unvested shares of Braze, Inc. subject to repurchase (in shares) (28) (181) (233)
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, basic (in shares) 94,569 34,897 17,972
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, diluted (in shares) 94,569 34,897 17,972
Earnings Per Share, Basic and Diluted [Abstract]      
Net loss per share attributable to Braze, Inc. common stockholders, basic (in dollars per share) $ (1.47) $ (2.20) $ (1.77)
Net loss per share attributable to Braze, Inc. common stockholders, diluted (in dollars per share) $ (1.47) $ (2.20) $ (1.77)
v3.23.1
Net Loss per Share - Schedule of Potentially Dilutive Securities (Details) - shares
shares in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of loss per share (in shares) 12,919 12,391 74,235
Convertible preferred stock on an as-converted basis      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of loss per share (in shares) 0 0 62,831
Options to purchase common stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of loss per share (in shares) 8,172 11,036 11,186
Restricted stock units      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of loss per share (in shares) 4,626 1,355 0
ESPP shares estimated to be purchased      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of loss per share (in shares) 121 0 0
Warrants to purchase common stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of loss per share (in shares) 0 0 218
v3.23.1
Related Party Transactions - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Related Party Transactions [Abstract]      
Purchases from related party $ 1,400 $ 1,200 $ 0
Expense with related party transaction $ 400    
v3.23.1
Subsequent Events - Narrative (Details) - RSUs - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2023
Feb. 28, 2023
Jan. 31, 2023
Subsequent Event [Line Items]      
Granted (in shares)     4,430,554
Unrecognized compensation costs (in thousands)     $ 114,730
Subsequent event      
Subsequent Event [Line Items]      
Unrecognized compensation costs (in thousands) $ 97,500 $ 4,900  
Requisite service period 3 years 4 years  
Subsequent event | Class A common stock      
Subsequent Event [Line Items]      
Granted (in shares) 2,914,105 148,362  
v3.23.1
Label Element Value
Accounting Standards Update [Extensible Enumeration] us-gaap_AccountingStandardsUpdateExtensibleList Accounting Standards Update 2014-09 [Member]